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Effectiveness and economic evaluation of self-help
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randomised controlled trial
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Background: Most people who quit smoking successfully for a short period will return to smoking again
in 12 months. A previous exploratory meta-analysis indicated that self-help booklets may be effective for
smoking relapse prevention in unaided quitters.
Objectives: This study aimed to evaluate the effectiveness of a set of self-help educational booklets to
prevent smoking relapse in people who had stopped smoking with the aid of behavioural support.
Design: This is an open, randomised controlled trial and qualitative process evaluation. Trial participants
were randomly allocated to one of two groups, using a simple randomisation process without attempts to
stratify by participant characteristics. The participant allocation was ‘concealed’ because the recruitment of
quitters occurred before the random allocation.
Setting: Short-term quitters were recruited from NHS Stop Smoking Clinics, and self-help educational
materials were posted to study participants at home.
Participants: A total of 1407 carbon monoxide (CO)-validated quitters at 4 weeks after quit date in NHS
Stop Smoking Clinics. The trial excluded pregnant women and quitters who were not able to read the
educational materials in English.
Interventions: Participants in the experimental group (n= 703) received a set of eight revised Forever Free
booklets, and participants in the control group (n= 704) received a single leaflet that is currently given to
NHS patients.
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Main outcome measures: Follow-up telephone interviews were conducted 3 and 12 months after quit
date. The primary outcome was prolonged, CO-verified abstinence from months 4 to 12 during which time
no more than five cigarettes were smoked. The secondary outcomes included self-reported abstinence
during the previous 7 days at 3 and 12 months, CO-verified abstinence at 12 months, costs (NHS and NHS
and participant medication costs perspectives) and quality-adjusted life-years. Logistic regression analyses
were conducted to investigate effect-modifying variables. A simultaneous qualitative process evaluation
was conducted to help interpret the trial results.
Results: Data from 1404 participants were used for the final analysis, after excluding three participants
who died before the 12-month follow-up. The proportion with prolonged abstinence from months 4 to
12 after quit date was 36.9% in the intervention group and 38.6% in the control group. There was no
statistically significant difference between the groups (odds ratio 0.93, 95% confidence interval 0.75 to
1.15; p= 0.509). There were no statistically significant differences between the groups in secondary
smoking outcomes. People who reported knowing risky situations for relapse and using strategies to
handle urges to smoke were less likely to relapse. However, there were no differences between the groups
in the proportion of participants who reported that they knew any more about coping skills, and no
differences in reported use of strategies to cope with urges to smoke between the trial groups. The
qualitative study found that some quitters considered self-help booklets unhelpful for smoking relapse
prevention, although positive feedback by participants was common.
Conclusions: Among quitters who had stopped smoking with the aid of intensive behavioural support,
there was no significant difference in the likelihood of smoking relapse between those who subsequently
received a set of eight revised Forever Free booklets and those who received a single leaflet. Although
many people had suboptimal strategies to prevent relapse and most relapsed, the Forever Free booklets
proved an ineffective medium for teaching them the skills to prevent relapse. Further research should focus
on interventions that may increase the use of coping skills when required.
Trial registration: Current Controlled Trials ISRCTN36980856.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 59.
See the NIHR Journals Library website for further project information.
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About half of the people who go to NHS Stop Smoking Clinics successfully stop smoking after severalweeks. However, 7 or 8 out of 10 people who stop smoking start to smoke again within 1 year. In this
study, we wanted to try to find out if a set of eight educational booklets (called Forever Free) could be
used to help more people to remain non-smokers after using NHS Stop Smoking Services.
Roughly half of our 1404 trial participants were sent eight educational booklets in the post and the other
half received a single leaflet currently used by the NHS (called Learning to Stay Stopped). We found that
people who attempted to do something to control their smoking urges were more likely to remain smoke
free. However, after 12 months, there were no differences in smoking status between the eight-booklets
group and the single-leaflet group. Interviews with some of the study participants told us that some
people liked the booklets and found them useful, although the booklets did not provide much additional
advice beyond what they had already been told by their stop smoking advisors. In conclusion, compared
with a single leaflet, the use of a set of eight educational booklets will not help more people to remain
non-smokers after using the NHS Stop Smoking Services.
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Smoking remains the leading preventable cause of premature deaths in the world. Pharmacotherapy and
behavioural support are effective in helping motivated smokers to stop smoking. However, relapse rates
among short-term quitters are high. In the NHS Stop Smoking Clinics, for example, about 75% of the
4-week quitters go back to regular smoking after between 4 and 52 weeks. The long-term success rates
still make these interventions highly cost-effective, but there is a need to find effective interventions to
reduce relapse rates after the initial treatment episode.
The results of previous systematic reviews indicated that the risk of smoking relapse may be reduced by
self-help educational materials in unaided quitters who are highly motivated to remain smoking abstinent.
Specifically, two randomised controlled studies found that the use of a series of eight booklets (Forever
Free) was cost-effective for the prevention of smoking relapse among unaided self-quitters.
Objective
The objective of this randomised controlled study was to evaluate the effectiveness and cost-effectiveness
of a set of eight Forever Free booklets in preventing smoking relapse in short-term quitters after intensive
behavioural and pharmacological treatments in smoking cessation clinics.
Methods
This was an open, parallel-arm, individually randomised controlled trial. A qualitative process evaluation
interviewed a purposive sample of trial participants, and also gathered views via focus groups of
health-care professionals.
Trial participants
The target population was carbon monoxide (CO)-verified, 4-week quitters treated in NHS Stop Smoking
Clinics who could read English and could give informed consent. The biochemically verified 4-week quitter
is defined as a treated smoker who reports abstinence from at least day 14 post quit date to the 4-week
follow-up point (or within 25–42 days of the quit date) and who blows an exhaled CO reading of < 10 parts
per million (p.p.m.). We excluded 4-week quitters who were pregnant, unable to read booklets in English,
from families at the same address and younger than 18 years. For participant recruitment, stop smoking
advisors in NHS Stop Smoking Clinics introduced the study, gained consent for participation from their clients
and collected baseline data. The trial co-ordinator or administrator randomly allocated recruited participants to
the treatment and control groups, using a computerised allocation system provided by the Norwich Clinical
Trials Unit.
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After randomisation, researchers posted the self-help materials to participants’ homes. The experimental
intervention was the full pack of eight Forever Free booklets. Booklet 1 is a brief summary of all issues
relevant to smoking relapse prevention. The remaining seven booklets provide more extensive information
on important issues for relapse prevention, entitled Smoking Urges; Smoking and Weight; What if You
Have a Cigarette?; Your Health; Smoking, Stress, and Mood; Lifestyle Balance; and Life without Cigarettes.
The original Forever Free Booklets were prepared for users in the USA. We revised and updated the
booklets in places where it was judged necessary or helpful, to make the material more suitable to British
users and the UK NHS. The control leaflet Learning to Stay Stopped is commonly used in practice and
contains brief but comprehensive information on issues related to smoking relapse and also provides brief
recommendations on how to cope with cravings and tempting triggers.
Data collection, outcome measures and sample size
Four weeks after the quit date, stop smoking advisors gathered baseline information from participants who
had consented to participate in the trial. Follow-up telephone interviews were conducted by researchers at
3 and 12 months after quit dates (or 2 and 11 months after enrolment). During the follow-up telephone
interviews, researchers asked participants about receipt and use of the booklets or leaflet and assessed
smoking-related outcomes. At the 12-month follow-up, participants who met the self-report criteria for at
least 7-day abstinence were invited to attend a local centre to prove this by exhaled CO. People came to a
clinic at the University of East Anglia or a researcher visited them at home for this test. To optimise CO test
rates, we offered a shopping voucher (valued £20) to each of the participants who attended the CO test.
The primary end point was prolonged abstinence from months 4 to 12, during which time no more than
five cigarettes in total were smoked, and confirmed by CO < 10 p.p.m. at the 12-month follow-up. The
secondary outcomes were 7-day self-report abstinence at 3 months (2 months after enrolment), 7-day
self-report and CO-validated abstinence at 12 months post quit date (11 months after enrolment).
We collected data on the resource use associated with self-help materials (including intellectual property,
adaptation, printing and postage), any additional Stop Smoking Services and cessation products, general
practitioner visits and hospital admissions at follow-up interviews. This enabled costs to be estimated from
the viewpoint of the NHS and for NHS and participant medication costs. The European Quality of Life-5
Dimensions-3 Level was used to estimate the benefits in terms of the quality-adjusted life-year (QALY)
during the study period.
Based on results of an exploratory meta-analysis, the prevalence of smoking abstinence at 12 months was
estimated to be 25.0% in the control group and 32.4% in the intervention group. Assuming α= 0.05
(type 1 error), 1 – β= 0.8 (statistical power) and a dropout rate of 15%, about 700 participants were
required in each arm. The target sample size for this trial was therefore 1400 in total.
The qualitative study sought a purposive sample of approximately 40 participants, selected for maximum
variation in core characteristics. Participants undertook separate consent for qualitative interviews at
12-month follow-up and were offered a £20 voucher as reimbursement for their time.
Data analysis methods
The comparison of smoking abstinence outcomes (and any other binary outcomes) between the two trial
groups was carried out using an odds ratio (OR) and its 95% confidence interval (CI) as the measure of
treatment effect. Participants who declined biochemical verification or who did not respond to follow-up
were classified as smokers, although participants who died or were known to have moved away were
excluded from the numerator and denominator.
SCIENTIFIC SUMMARY
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We used exploratory subgroup and logistic regression analyses with interaction terms to investigate
possible effect-modifying variables. Association between mediating variables (use of booklets or leaflet)
and smoking abstinence at 12 months was also quantitatively investigated by logistic regression or
subgroup analyses. We conducted a qualitative process evaluation using data collected as part of the trial
telephone follow-up interviews, and a further qualitative substudy of in-depth data collection. As part of a
within-trial cost–utility analysis, based on the complete-case approach, regression analysis was used to
estimate the mean incremental cost and QALY gain associated with the intervention.
Qualitative data were analysed following a grounded theory approach, inductively drawing out key themes
of importance to participants. We explored views of the content, usefulness and practical use of the
self-help relapse prevention materials. Analysis was undertaken iteratively alongside data collection and
continued until saturation of themes was reached. Analysis was developed through triangulation of data
sources, by also collecting the views of health-care professionals and feeding back findings in final
participant focus groups.
Results
We randomly allocated 1407 eligible short-term quitters to the intervention or the control group. The
participants in the two groups were comparable at baseline in terms of demographic and smoking-related
variables. The follow-up rate was 93% at the 3 months and 86% at the 12 months. Three participants
who died before the 12-month follow-up were excluded from the final data analysis. At the 12-month
follow-up, 725 participants reported abstinence in the previous 7 days and were eligible for a CO test.
Verification tests were carried out for 616 of these participants, while 109 participants declined or were
unable to have the test.
Smoking abstinence results
The primary outcome was prolonged, CO-verified smoking abstinence from month 4 to 12, during which
time no more than five cigarettes were smoked. The proportion of prolonged abstinence was 36.9% in
the intervention group and 38.6% in the control group, and there was no statistically significant difference
between the intervention and the control group (OR 0.93, 95% CI 0.75 to 1.15).
The 7-day self-report point prevalence of smoking was on average 21% at 3 months and 48% at 12 months,
and there were no statistically significant differences between the intervention and the control groups
(OR 0.99, 95% CI 0.76 to 1.27, at 3 months and OR 1.03, 95% CI 0.84 to 1.27, at 12 months). The
CO-verified smoking abstinence at 12 months was 44% on average, and again there was no difference
between the two groups (OR 1.02, 95% CI 0.83 to 1.26). Exploratory analyses found that the relative effect
was not statistically significantly associated with participant characteristics at baseline.
Baseline variables and smoking abstinence at 12 months
Carbon monoxide-validated, prolonged smoking abstinence from month 4 to 12 was not statistically
significantly associated with sex, education or the receipt of free prescriptions. However, older age was
statistically significantly associated with prolonged smoking abstinence from 4 to 12 months (p= 0.011).
In addition, the increased risk of smoking relapse was significantly associated with marital (single, separated
or divorced compared with married or living with a partner) and employment status (unemployed compared
with in paid employment).
Prolonged smoking abstinence from 4 to 12 months was not associated with stated reasons for quitting, stated
importance, stated determinations or perceived chances of staying off cigarettes for good. Quitters who were
treated by specialist level 3 advisors were less likely to return to smoking than those recruited from other types
of Stop Smoking Services (p= 0.023). The increased risk of smoking relapse was associated with living with a
smoking partner (p= 0.046), time to first cigarette after waking (p= 0.005), smoking more than 10 cigarettes
per day before quitting (p= 0.001) and any previous quit attempts (p= 0.001).
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Process and mediating variables
The percentage of participants who reported that they still possessed the booklets was higher in the
treatment group than in the control group at the 3-month (83% vs. 62%) and 12-month follow-up (49%
vs. 35%). There was no significant difference in the percentage of participants who reported that they had
read the booklets or leaflet at 3 months (70% vs. 69%) and between 4 and 12 months (27% vs. 21%).
Participants in the intervention group reported spending somewhat more time reading the booklets than
control group participants.
The proportion of participants who reported that reading the booklets taught them no more than they
knew already was lower in the treatment group at the 3-month follow-up (48% vs. 53%), but there was
no difference between the groups at 12 months (49%). There were no significant differences between the
groups in the percentages of participants who reported that reading the booklets taught them more about
ways to handle urges to smoke at 3 and 12 months.
The percentage of all participants who reported one or more strategies was 87% at the 3-month follow-up
and 65% at the 12-month follow-up, and there was no significant difference between the two groups.
About 83% of all participants by 3 months and 60% between 4 and 12 months reported enacting a
strategy to handle urges to smoke, with no significant differences between the groups.
Prolonged smoking abstinence from 4 to 12 months was statistically significantly associated with booklet
reading by 3 months (p< 0.001), but not between 4 and 12 months (p= 0.759). The risk of relapse by
12 months was lower in participants who reported knowing more about risky situations or knowing more
ways to handle urges because they had read the booklets. Participants who reported doing something to
handle urges to smoke were less likely to relapse by 12 months than people who had no strategy to cope
with urges. Of participants who reported they had tried to handle urges between 4 and 12 months, 48%
remained smoking free by 12 months, compared with 23% of those who did not report a strategy.
Qualitative investigation results
With regard to the intervention booklets, participants seem either to be very motivated and to have really
engaged with the booklets or to have disliked the booklets and in some cases not read them at all. For
those reporting negative feelings towards the booklets, the overall sense was that the booklets did not
offer any particularly new or novel insights to what was already known about smoking relapse prevention.
Participants were often able to recall advice delivered face to face, but found it more difficult to recall
content of the trial intervention booklets.
Economic evaluation results
There was no significant difference in mean costs or mean QALY scores between the intervention and
control groups. Although the estimated mean incremental net benefit was positive [£74.79 in the base
case at the (λ) value of £20,000 per QALY], the probability of cost-effectiveness was estimated to be
only 64.4% according to the cost-effectiveness acceptability curve. Coupled with the aforementioned
effectiveness results, this would suggest that we are not able to conclude that the provision of the
intervention booklets is cost-effective.
SCIENTIFIC SUMMARY
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Discussion
The current trial had adequate statistical power, so the result is unlikely to be a false negative. Whereas
the present study found no differences in smoking abstinence by 12 months between the experimental
and control interventions, the previous studies of the Forever Free booklets for smoking relapse prevention
reported statistically significant group differences among unaided quitters. The Forever Free booklets were
originally developed to aid self-quitters in place of more intensive face-to-face treatment, and the previous
studies involved those smokers. In contrast, all participants of the current trial had received intensive
behavioural support from stop smoking advisors before participating in the trial, and most of them (89%)
had previous quit experience. Therefore, it is very likely that they had received information from stop
smoking advisors similar to that in the Forever Free booklets. In addition, participants in the control group
received a single leaflet containing the similar but much briefer points for smoking relapse prevention.
The qualitative interviews found that study participants could recall some advice received from stop
smoking advisors, while they found it difficult to recall information contained in the booklets.
Conclusions
There was no significant difference in smoking relapse between a set of eight revised Forever Free booklets
and a single leaflet for the prevention of smoking relapse in quitters who had stopped smoking with the
aid of intensive behavioural support. The risk of smoking relapse could not be reduced simply by posting
more information to CO-validated 4-week quitters in NHS Stop Smoking Services.
Recommendations for research
1. Actual use of coping skills is associated with a lower risk of long-term smoking relapse. Further research
should focus on interventions that may increase the use of coping skills when required.
2. Reasons for different longer-term smoking outcomes across different studies and among individual
4-week quitters need to be investigated. Improved understanding of variables related with smoking
relapse may help develop novel interventions for smoking relapse prevention.
Trial registration
Current Controlled Trials ISRCTN36980856.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction and objectives
Smoking remains the leading preventable cause of premature deaths in the world.1 Cigarette smokerslose about 10 years of lifespan compared with people who never smoke, although the risk of excess
mortality can be considerably reduced by stopping smoking.2 It is estimated that tobacco use was
responsible for about 100 million deaths globally in the 20th century,3 and it kills about 6 million people
each year in the 21st century.1
Among adults (aged ≥ 16 years) in England, the prevalence of smoking was 20% in 2010, which
was considerably lower than in 2000 (27%), and much lower than in 1980 (39%).4,5 Two-thirds of current
smokers in England report wanting to quit smoking and three-quarters have tried to do so in the past.
Compared with many other countries, the percentage of former smokers among ever-smokers (former
or current) in adults is relatively high in England, about 57% for men and 51% for women.4–6
Pharmacotherapy and behavioural support are effective in helping motivated smokers to stop smoking,7–10
although relapse rates following these interventions are high.11 Since 2001, a national network of NHS Stop
Smoking Services has been established in England to provide behavioural support and pharmacotherapy to
smokers who would like to quit. The English Stop Smoking Services were overseen by primary care trusts
until April 2013, and have been overseen by local authorities since then. In 2010/11, 787,527 people
(8% of all smokers) used NHS Stop Smoking Services, which generated 269,293 biochemically validated
quitters (34% of those who set a quit date) at 4 weeks after the quit date.12 However, about 75% of
4-week quitters go back to regular smoking after between 4 and 52 weeks.13 The long-term success rates
still make these interventions highly cost-effective14 but there is a need to find effective interventions to
reduce relapse rates after the initial treatment episode.
Interventions for smoking relapse prevention
Interventions for smoking relapse prevention are generally based on the cognitive–behavioural approach
to coping skills training15 and may be considered as complex health-care interventions with multiple
interacting components.16,17 For the development and evaluation of complex interventions, we need a
good theoretical understanding about how the intervention causes change.17 With the coping skill training
approach, quitters are trained to anticipate situations associated with high risks of smoking relapse (such
as going out with friends or feeling frustrated), and to develop skills to cope with such situations and urges
to smoke again. Therefore, the effectiveness of coping skills training for relapse prevention will depend
on (1) the delivery and receipt of interventions, (2) the acquiring of coping skills by quitters and (3) the use
of such skills in high-risk situations. To benefit from coping skills training, quitters need to learn, practise
and implement coping skills when required.18
A Cochrane systematic review of trials of smoking relapse prevention found insufficient evidence to
support the use of any specific intervention for preventing smoking relapse in short-term quitters.19 The
current smoking cessation guidelines do not recommend any specific interventions for smoking relapse
prevention.20,21 According to findings from a survey of smoking cessation professionals, the uncertain
evidence base about effectiveness was an important barrier to the use of relapse prevention interventions
in stop smoking practice.22
We conducted an exploratory meta-analysis in 2009 using data from 49 trials on psychoeducational
interventions for smoking relapse prevention.23 The meta-analysis showed that coping skills training interventions
significantly reduced smoking relapse in community quitters who had stopped smoking for at least 1 week at
baseline [odds ratio (OR) 1.44, 95% confidence interval (CI) 1.14 to 1.81], although it was ineffective for current
smokers, pregnant or postpartum quitters, hospitalised ex-smokers, forced short-term quitters and smokers with
mental illness or drug abusers.23 Therefore, it seemed that coping skills training may be effective in secured
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quitters who are highly motivated to remain abstinent. In addition, available evidence indicated that self-help
educational materials may be as effective as interventions based on individual or group counselling for smoking
relapse prevention. The pooled OR of relapse prevention associated with coping skills training was 1.46 (95% CI
1.05 to 2.05) for self-help material trials and 1.41 (95% CI 1.02 to 1.94) for counselling trials.23 A systematic
review conducted by an independent team also found that written self-help materials were efficacious for
preventing smoking relapse in unaided quitters.24
Forever Free booklets
Brandon and colleagues developed a series of eight booklets to be used as self-help materials for smoking
relapse prevention and have evaluated the booklets in two randomised controlled trials in the USA.25,26
Volunteers who had quit smoking unaided were randomised to receive either all eight booklets or only the
introductory booklet. Participants who received all eight booklets had a lower rate of smoking relapse than
participants who received only a single booklet (the introduction booklet). One of the two randomised
studies of Forever Free booklets found that repeated mailing (high contact) was no more effective than
massed mailing (low contact) of the eight booklets.26 It has been suggested that the true effectiveness of
Forever Free booklets might have been underestimated because participants in the control group received
the introduction booklet that provided a summary of all relevant skills. The use of the Forever Free booklets
for smoking relapse prevention was likely to be highly cost-effective [US$83–US$160 per quality-adjusted
life-year (QALY) gained].26
Objective
Existing trials on coping skills training for smoking relapse prevention in community quitters recruited
unaided quitters mainly by advertisement in newspapers and were mostly conducted in the USA. It is
uncertain whether or not the results of meta-analysis23 and randomised controlled studies in the USA25,26
are generalisable to 4-week quitters who used the NHS Stop Smoking Services. A Health Technology
Assessment (HTA) report recommended further research on the effectiveness of self-help interventions for
smoking relapse prevention.27
The objective of this randomised controlled study was to evaluate the clinical effectiveness and
cost-effectiveness of self-help materials (Forever Free booklets) in preventing smoking relapse in 4-week
quitters who have used NHS Stop Smoking Services.
INTRODUCTION AND OBJECTIVES
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Chapter 2 Methods and design
The study design was a parallel-arm pragmatic individually randomised controlled trial to evaluate theeffectiveness of self-help educational material (Forever Free booklets) in preventing smoking relapse,
compared with a smoking cessation booklet used currently. The trial protocol was published in an open
access journal.28
This was an open trial, without attempts to blind investigators and patients after randomisation. Because
the outcome assessor and trial participants know the allocated intervention, bias may be introduced
into the results. However, evidence suggested that the risk of bias may be much reduced in trials with
objectively assessed outcomes.29 In this trial, the primary outcome was biochemically verified abstinence
at 12 months, which can be considered an objectively assessed outcome.
Setting
We planned to recruit 4-week quitters in NHS Stop Smoking Clinics in Norfolk, using specialist stop smoking
advisors (these are specially trained stop smoking advisors who work exclusively in delivering smoking cessation
advice and support). In comparison with all of England, Norfolk has a relatively high percentage of people aged
65 years and above (21.4% vs. 16.5% in 2010) and has a higher percentage of European white people
(94.3% vs. 87.5% in 2009). Of those who set a quit date in 2010/11, the percentage of self-reported
successful quitters was 52%, compared with an average of 49% in England.30
After 7 months of recruitment, the number of participants recruited was under target and it was clear that
we would not be able to achieve the study recruitment target from the specialist advisors in Norfolk alone.
Consequently, recruitment was extended to include level 2 advisors (these are health-care professionals
such as pharmacists, practice nurses or health-care assistants who are also trained in administering
smoking cessation advice and support) in general practice and/or community pharmacies in Norfolk that
had recruited 12 or more carbon monoxide (CO)-verified quitters in 2010/11. Participant recruitment was
later further extended to include 4-week quitters from Suffolk, Hertfordshire, Lincolnshire, and Great
Yarmouth and Waveney.
The investigated self-help educational materials were posted to trial participants for their use at home.
At the final follow-up (12 months after quit date), participants who reported that they had not smoked
during the previous 7 days were invited to have a breath CO test to confirm the self-reported status of
non-smoking. The test was carried out by a researcher from the University of East Anglia (UEA) in Norwich.
Study participants came to a clinic at the UEA, or a researcher visited them at home for this test.
Participant recruitment
Smokers who are motivated to quit are referred to the NHS Stop Smoking Clinics from various sources,
such as by general practitioners (GPs), or are self-referred. Clients who contact the Stop Smoking Service
are given an appointment for assessment with a stop smoking advisor, either individually or in group
sessions. Following assessment, the client typically receives weekly behavioural support, focused on
withdrawal-oriented therapy, with medication to reduce craving and withdrawal. The total contact time for
each client is at least 1.5 hours from pre-quit preparation to 4 weeks after quitting. The self-reported
abstinence at 4 weeks after the quit date is about 50%, and the biochemically verified abstinence ranges
from 31% to 36%.12 However, most (75%) self-reported 4-week quitters will relapse by 12 months.13
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The target population for this trial was CO-verified, 4-week quitters treated in NHS Stop Smoking Clinics
who can read English and could give informed consent. According to NHS Stop Smoking Services
guidance,31 the biochemically verified 4-week quitter is defined as ‘a treated smoker whose CO reading is
assessed 28 days from their quit date (–3 or +14 days) and whose CO reading is less than 10 ppm (parts
per million)’. That is, a face-to-face follow-up interview should be normally conducted 4 weeks from the
quit date. Where a follow-up at 4 weeks is impossible, it should be conducted 25–42 days after the quit
date (the Russell Standard).31
Inclusion criteria
l Carbon monoxide-verified 4-week quitters in the NHS Stop Smoking Service clinic who sign the
consent form were eligible to participate in the trial.
Exclusion criteria
l Pregnant quitters were excluded. The process of relapse in pregnant women is very different from
non-pregnant smokers. According to the available research evidence,23 smoking relapse prevention
intervention by coping skills training is ineffective for women who have stopped smoking
during pregnancy.
l We excluded quitters who were not able to read the educational material in English because the
revised booklets are available in English only.
l We excluded quitters from families at the same address, as a family member has already been included
in the trial.
l Quitters younger than 18 years were not included.
Training of stop smoking advisors for participant recruitment
For participant recruitment, stop smoking advisors introduced the study, gained consent for participation
from their clients and collected baseline data. For this role, they received a half-day’s training. This
consisted of:
l outline of study, including flow diagram
l baseline questionnaire, including group activity: completing baseline questionnaire
l informed consent
l spot the mistakes: demonstration by co-ordinators of how not to consent participation
l group activity role-play: undertaking informed consent
l distribution of study materials.
The recruitment period was 24 months, so it was important to sustain the recruiters’ interest for the
duration of this period and engender their ownership of the project. Consequently, training continued
throughout the whole study. Co-ordinators regularly attended the stop smoking advisors’ team meetings,
where ongoing training was given to reinforce the study procedures, along with reporting of study
updates. In addition, two evening refresher sessions were held, which consisted of:
l smoking cessation research evidence
l study updates
l role-play demonstrating recruitment techniques
l quiz about targeted study procedures
l opportunity for suggestions from recruiters about how to optimise recruitment.
When recruitment was extended to include level 2 advisors, and other counties, initial training was
delivered by the co-ordinators to small groups or one to one; sometimes this was then cascaded down
to other advisors at the recruitment sites. All recruiters signed a training record on completion of the
initial training.
METHODS AND DESIGN
NIHR Journals Library www.journalslibrary.nihr.ac.uk
4
Trial procedures and randomisation
Stop smoking advisors completed a study screening form for each of their clients, and introduced the study
to them, by giving them a participant information sheet, containing information on the trial. Then, at the
final session in the Stop Smoking Clinic (4-week post quit, when all self-reported quitters undergo a breath
CO test), the advisor again explained the nature of the trial to CO-verified quitters only, answered
questions from them, and invited them to participate in the trial by signing the consent form. Clients who
had failed to quit were not invited to participate in the study.
After eligible quitters had signed the consent form, stop smoking advisors asked participants to complete
the baseline questionnaire, which they sent to the trial co-ordinator at the UEA, along with the screening
form and a copy of the consent form. On receipt of these documents, the trial co-ordinator or trial
administrator randomly allocated participants to two groups (the treatment and control group), using a
computerised allocation system provided by the Norwich Clinical Trials Unit (CTU). We adopted a simple
randomisation process, without attempts to stratify by participant characteristics. This allocation of trial
participants was concealed because the recruitment of quitters occurred before the random allocation.
As it was necessary to avoid possible information contamination across the trial arms and non-independence
between members of the same family or household, we screened all eligible participants and checked their
address against recruited participants to ensure that no two people from the same household were
recruited. Where two people of the same family or household were found eligible and willing to participate
at the same time, we randomly selected only one of them to participate in the trial. If the members of the
same family used the NHS Stop Smoking Service at different times during the trial recruitment period, we
included only the first family member.
We expected that many people would make repeated attempts to quit using the Stop Smoking Service
during the trial period, so, to ensure that clients participated in the study only once, stop smoking advisors
checked if the ‘new’ quitter had already been included in the trial. In addition, the trial co-ordinators
and/or administrator also checked this to make sure a quitter was not already recruited onto the study.
Interventions investigated
The experimental intervention tested in the trial was the full pack of eight Forever Free booklets. Findings
from an exploratory meta-analysis suggested that coping skills training may be effective for smoking
relapse prevention in motivated quitters.23 The results of two clinical trials in the USA suggested that a
cheap intervention using Forever Free booklets25,26 may be as effective as more expensive counselling
for coping skills training. Forever Free booklets include a series of eight booklets (Table 1). Booklet 1
(with 17 pages) is a brief summary of all relevant issues, including an introduction of nicotine dependence,
the stages of smoking cessation, situations that are high risk for relapse, ways of coping with urges to
smoke, the abstinence violation effect and ways to handle an initial slip. The remaining seven booklets
provide more extensive information on important issues for relapse prevention, entitled Smoking Urges;
Smoking and Weight; What if You Have a Cigarette?; Your Health; Smoking, Stress, and Mood; Lifestyle
Balance; and Life without Cigarettes. The booklets can be understood by people with a reading level of
fifth to sixth grade in the USA (expected reading level for children aged 10–12 years).
The original Forever Free Booklets were prepared for users in the USA. We revised and updated the
booklets in places where it was judged necessary or helpful, to make the material more suitable to British
users and the UK NHS. We obtained permission from the copyright holders (H Lee Moffitt Cancer Center
and Research Institute, Tampa, FL, USA). Members of the Trial Steering Committee, and of the project
team and three lay representatives reviewed and commented on the revised booklets. During their
modification, we ensured the acceptability and understanding of the booklets to as wide a range of users
as possible. The revised booklets are currently available only in English because of the considerable cost
implications of translating the booklets into other languages.
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After randomisation, the research team sent the corresponding self-help material by post to participants’
homes. Participants in the intervention group received a letter and all eight Forever Free booklets, which
were posted by normal delivery. The first 10 intervention packages were posted by special delivery to
confirm that the booklets could be posted through participants’ letter boxes; no delivery was returned,
confirming that the booklets were successfully delivered. Participants in the control group received a letter
and a booklet about smoking cessation, Learning to Stay Stopped.32 The leaflet (with eight pages in total)
used in the control group contains brief but comprehensive information on issues related to smoking
relapse and also provides brief recommendations on how to cope with cravings and tempting triggers
(see Table 1). It is commonly used in NHS Stop Smoking Services.
TABLE 1 Contents of self-help educational materials investigated in the study
Material Contents (booklets) or headings (leaflet)
Experimental intervention: Forever Free: A Guide to Remaining Smoke Free
Booklet 1: An Overview (16 pages) About Forever Free; Seven facts about smoking and quitting; The
stages of quitting; ‘Risky’ situations for ex-smokers; How to handle
urges to smoke; A non-smoking lifestyle; What if you DO smoke;
The most important messages
Booklet 2: Smoking Urges (11 pages) What are urges?; Different types of urges; How to deal with urges to
smoke; When will the urges end?; Exercises; Remember . . . ; Notes
Booklet 3: Smoking and Weight (15 pages) Why a booklet on weight control after quitting?; Who gains
weight?; Why do ex-smokers gain weight?; Do I have to gain
weight?; Effects of smoking and weight gain on health and looks;
Weight control after quitting; Exercise; Make exercise part of your
day; Summary
Booklet 4: What if I Have a Cigarette? (7 pages) Can’t I have just one cigarette? Be prepared for a slip; Watch out
for the effects of a slip; Keep a slip from turning into a full
relapse; Summary
Booklet 5: Your Health (11 pages) Why this booklet?; How harmful is smoking?; What makes
smoking so harmful?; What happens when you quit smoking?;
Quitting smoking helps others, too; How can this information help
you stay quit?; If you are smoking again
Booklet 6: Smoking, Stress and Mood (11 pages) What causes stress?; What is stress?; How is stress related to
smoking?; What leads up to a cigarette; So, why not smoke when
stressed?; Better ways to deal with stress and negative moods
Booklet 7: Lifestyle Balance (15 pages) Stress; ‘Shoulds’ versus ‘Wants’; Your daily hassles; Your ‘Shoulds’;
Your ‘Wants’; Positive addictions; Summary; Pleasant events list
Booklet 8: Life without Cigarettes (11 pages) Urges; Benefits of quitting; But what about my weight; If you do
smoke; In closing
Control leaflet: Learning to Stay Stopped
Learning to Stay Stopped (including covers, eight
pages; recommended 10 minutes to read through)
Congratulations on stopping smoking!; Learning to stay stopped;
Nicotine withdrawal; Psychological dependence; Having doubts
about quitting?; Constantly thinking about smoking?; Worried
about weight gain?; Bored with quitting?; Over reacting to
things?; Strong cravings?; Tempting triggers?; Tired of dealing
with triggers?; Smoked a cigarette? (Note: provided a short list
about ‘What you can do!’ following each of the above problems)
METHODS AND DESIGN
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Sample size calculation
Without smoking relapse prevention, about 75% of CO-validated 4-week quitters would go back to
regular smoking between 4 and 52 weeks.13 An exploratory meta-analysis indicated that coping skills
training interventions may reduce smoking relapse in community quitters who had stopped smoking for
at least 1 week (OR 1.44, 95% CI 1.14 to 1.81).23 Therefore, the abstinence rate of 4-week quitters at
12 months was estimated to be 25.0% in the control and 32.4% in the intervention group (based on an
OR of 1.44). Assuming α= 0.05 (type 1 error) and 1 – β= 0.8 (statistical power), about 590 participants
were required in each arm.33 Assuming a dropout rate of 15%, about 700 participants were required in
each arm (1400 in total).
Outcomes and data collection
At the session about 4 weeks (or 25–42 days)31 after the quit date, stop smoking advisors gathered
baseline information from participants who had consented to participate in the trial. The information
collected included participants’ demographic characteristics, smoking and quitting history, and level of
determination and confidence to remain abstinent.
The specified primary outcome was prolonged, CO-verified smoking abstinence from months 4 to 12,
with no more than five cigarettes being smoked during this period. This is in keeping with the consensus
statement of the Society for Research on Nicotine and Tobacco, and the Russell Standard.34,35 The usual
definition of prolonged abstinence allows a 2-week grace period following quit day, in which lapses do not
invalidate abstinence, to assess the outcome of aid to cessation trials. However, a relapse prevention
intervention might prevent lapses (occasional smoking) becoming relapses (regular smoking and abandonment
of the attempt to keep abstinent). Therefore, we used a 2-month grace period during which lapses to smoking
do not count against achieving abstinence. As participants on enrolment were abstinent at 4 weeks after quit
date, this equated to the primary outcome being prolonged abstinence from 4 months to 12 months after
quit date. Following the Russell Standard, the primary outcome was prolonged abstinence from months 4 to
12, with smoking of no more than five cigarettes in total, and confirmed by CO< 10 p.p.m. at the 12-month
follow-up.
The secondary outcomes were 7-day self-report abstinence at 3 months, 7-day self-report and CO-validated
abstinence at 12 months post quit date. We did not specify continuous abstinence from 2 to 12 months post
quit date as a secondary outcome in the trial protocol. Because continuous abstinence from 2 to 12 months
was used in previous studies, we added it as an outcome measure in the stage of data analysis, in order to
compare results between different studies. The continuous abstinence was defined as CO-verified smoking
abstinence at 12 months and no more than five cigarettes from 2 to 12 months after the quit date.
We assessed cost-effectiveness from an NHS perspective. We collected data on the resource use associated
with self-help materials (including intellectual property, adaptation, printing and postage), any additional
Stop Smoking Services and cessation products at follow-up interviews. Our hypothesis was that the
intervention, if effective, would improve abstinence rates, would reduce repeated use of Stop Smoking
Services and might reduce use of other health care. Other resources which might be affected by the
intervention were also monitored, including GP visits and hospital admissions. The European Quality of
Life-5 Dimensions-3 Level (EQ-5D-3L)36 was used to estimate the benefits in terms of the QALY gain
associated with each intervention during the study period.
Study participants were followed up by a researcher from the UEA 2 months after recruitment (which was
3 months after quit date) and again 11 months following recruitment (12 months after quit date). The
follow-up interviews were conducted by phone and involved the researcher administering a questionnaire
which asked questions about the participant’s smoking status, process variables and the use of stop
smoking and other NHS services.
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At 3 months after quit day (2 months after enrolment), a researcher from the UEA telephoned participants
primarily to assess process measures, that is receipt, liking and use of the booklets, and to assess key skills;
the booklets were intended to teach in both the intervention and the control groups. If the intervention
was ineffective, this would help us to assess whether the intervention was used but people did not acquire
the skills or applying the skills was ineffective in preventing relapse. This early follow-up contact was
important because of the high risk of relapse during the first few months.
The second and final follow-up telephone call (conducted by a researcher from the UEA) took place at
12 months after quit day (11 months after enrolment), to assess the primary and secondary outcomes and
to assess coping skills acquired. Participants who met the self-report criteria for at least 7-day abstinence
were invited to attend a local centre to prove this by exhaled CO. People came to a clinic at the UEA or a
researcher visited them at home for this test. To optimise CO test rates, we offered a shopping voucher
(valued at £20) to each of the participants who attended the CO test at 12 months. If participants found
it difficult to travel to the UEA, then researchers arranged to visit them at home, at a time convenient to
the participant, including at evenings and weekends (46% of Norfolk CO tests were undertaken at
participants’ homes). At non-Norfolk sites, local testing was arranged for the CO tests: at stop smoking
shops in Lincolnshire, in participants’ homes in Suffolk and by local primary care research network nurses
in Hertfordshire.
When arranging CO tests, if participants were willing but unable to commit to a time during the follow-up
phone call, researchers phoned participants at a later date. If contact was not successfully made by phone,
researchers sent a letter to participants inviting them to phone the research team to make a CO test
appointment. When an appointment was successfully booked, participants were sent a letter confirming
the appointment arrangements. To minimise non-attendance at CO test appointments, participants were
sent a postcard a few days before the appointment and then phoned on the morning of the appointment.
Travelling expenses were reimbursed to participants and a £20 ‘Love2shop’ shopping voucher (for use in
many high-street shops) was given, in recognition of their time.
To optimise follow-up, researchers recorded all phone call attempts to participants (ranged from one to
seven phone calls), and tried different days and varying times of days to be able to talk to participants,
including evenings and Saturdays. Researchers also sent text messages to participants to arrange follow-ups,
which also helped to increase follow-up response. If researchers were unsuccessful in contacting a
participant by phone, they would then post the questionnaire, with a stamped addressed envelope, to the
participant’s home. If there was no response within 2 weeks, then a second questionnaire would be posted;
5.3% of 3-month questionnaires were received by post and 6.8% of 12-month questionnaires. When
completed postal questionnaires were received, the participants were posted a brief letter of thanks from
the research team.
Data management and analysis methods
Paper data were held in accordance with the Data Protection Act 1998.37 The questionnaire data were
identified by a unique study number, securely held in a locked filing cabinet, in a locked research office,
in a corridor of research/academic offices with restricted swipe access; participants’ personal information
was kept in a separate locked filing cabinet. Two Microsoft Excel® databases (2013; Microsoft Corporation,
Redmond, WA, USA) were created for the study by the Norwich CTU, one containing participants’
personal information and the other questionnaire data. Data entry was carried out by the UEA research
team, and a 10% data entry check was undertaken. Data analyses were conducted using Stata software
(Stata/IC for Windows, StataCorp LP, College Station, TX, USA).
METHODS AND DESIGN
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The comparison of smoking abstinence rates (and any other binary outcomes) between the two trial
groups was carried out using OR and its 95% CI as the measure of treatment effect, although estimated
risk ratio was also reported for the primary end point. Participants who declined biochemical verification or
who did not respond to follow-up were classified as smokers. However, participants who died or were
known to have moved away were excluded from the numerator and denominator. Because there were no
significant differences in missing data between the groups, we did not use imputation methods to assess
the robustness of primary analyses.38
We planned to compare survival curves of the intervention and control arm, by using data on time to the
first event of smoking relapse. This secondary analysis was not conducted because of inadequate reporting
of time the first relapse occurred by a large proportion of relapse participants.
We used exploratory subgroup analyses and logistic regression analyses with interaction terms to investigate
possible effect-modifying variables, including age, gender, socioeconomic status, level of nicotine dependence,
number of prior quit attempts and use of pharmacological interventions.
The analysis of mediating variables examined hypothesised mechanisms of the intervention. The effectiveness
of coping skills training for relapse prevention depends on (1) the adequate delivery and receipt of the booklets,
(2) the acquisition of coping skills by quitters and (3) the application of such skills in high-risk situations.
This intervention mechanism suggests certain important process variables that should be investigated in the trial.
At the follow-up interviews, we asked trial participants if they had received the booklets and if they had read
the booklets (and how much time spent and how many booklets looked at). We then investigated whether
or not the use of booklets helped the acquisition of coping skills by the participants, in terms of improved
capability to identify risky situations and to know more appropriate ways of handling urges to smoke again.
We then asked the trial participants whether or not they had actually applied the skills learnt from the booklets.
Finally, we invited the trial participants to give an overall assessment of the usefulness of the booklets. We also
planned to use more complex methods for the exploratory mediation analysis according to MacKinnon and
Fairchild39 but did not because there were no differences in the primary or any secondary outcomes between
the treatment and control group.
Qualitative process evaluation
We conducted a qualitative process evaluation using data collected as part of the trial telephone follow-up
interviews and a further qualitative substudy of in-depth data collection. Methods used for the qualitative
process evaluation are described in Chapter 6.
Economic evaluation methods
Using data from the trial, we calculated the mean incremental cost for those in the intervention arm
(Forever Free booklets), compared with the control arm. As part of a cost–utility analysis, the incremental
QALY gain associated with the intervention was estimated, based on EQ-5D data collected in the trial.
Chapter 7 provides more details about the economic evaluation methods used in the trial.
Ethical arrangements
No adverse effects or harm on target population or society was expected from the intervention.
We provided sufficient information for 4-week quitters to consider whether or not they would like to
participate in the trial and recruited only those who signed the consent form. Data on individual
participants remained strictly confidential. Only the project researchers directly involved in the trial had
access to participants’ personal data during the study. Research ethical approval was granted by East of
England Research Ethics Committee (11/EE/0091, approval received on 20 April 2011), and any protocol
amendments were approved by the Research Ethics Committee.
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A Trial Steering Committee was established to provide overall supervision for the study on behalf of the
National Institute for Health Research (NIHR) HTA programme. The trial was overseen by a trial
management group, based at the UEA, including all co-investigators. The trial management group met
every 3 months to monitor and manage the trial and to review an ongoing Consolidated Standards of
Reporting Trials statement (including data on recruitment, intervention and follow-up). The trial project
team, consisting of the trial co-ordinators, project administrator and chief investigator, met weekly to
monitor the day-to-day progress and management of the trial.
No adverse effects were expected to be associated with the educational booklets for smoking relapse
prevention. This trial posed no substantial risks to participants and there would be no cause to propose
stopping rules for premature closure of the trial. In addition, this trial is open and unblinded. After a
discussion with the NIHR HTA programme, we decided not to have a separate data monitoring committee.
Three members of the public contributed to the revision of the Forever Free booklets, and one lay
representative was on the trial steering committee.
METHODS AND DESIGN
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Chapter 3 Main results
Participant flow
The study started in June 2011. We used 2 months to revise and print the Forever Free booklets, and to
arrange trainings for stop smoking advisors who were involved in the recruitment of 4-week quitters.
Participant recruitment started in August 2011. We initially recruited CO-validated 4-week quitters from
the core Stop Smoking Clinics (level 3 stop smoking advisors) in Norfolk. By January 2012, we realised
that the recruitment rate was slower than expected. From May 2012, the participant recruitment was
expanded to level 2 stop smoking advisors and to new sites in Norfolk, Suffolk, Hertfordshire, Lincolnshire,
and Great Yarmouth and Waveney. By June 2013, the recruitment target was achieved and the trial
included a total of 1416 short-term quitters. The follow-up of participants, including CO test, was
completed by July 2014.
Table 2 shows the number of participants by area and service type, and Figure 1 shows the number of















































































































































































































FIGURE 1 Number of participants recruited by month.
TABLE 2 Participant recruitment by area and service type
Area Specialist service General practice Health trainer Pharmacy Total
Norfolk 1040 97 57 14 1208
Suffolk – 57 – 18 75
Hertfordshire – 68 – 7 75
Lincolnshire 51 – – – 51
Great Yarmouth and Waveney 7 – – – 7
Total 1098 222 57 39 1416
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The participant flow diagram is shown in Figure 2. From August 2011 to June 2013, there were a total of
1959 short-term quitters who were considered potentially eligible by stop smoking advisors. The number
of eligible quitters who declined to participant in the studies was 370 (19%), for various reasons. Before
randomisation, 173 (9%) were excluded for the following reasons: pregnancy (n= 26), family member in
study (n= 71), unable to read (n= 41), prior participant (n= 34) and other (n= 1).
Identified as eligible – verified 4-week quitter
(n = 1959)
Randomised
(n = 1416; 72%)
Allocated to control group
(n = 708; 50%)
Allocated to intervention group
(n = 708; 50%)
Not eligible (n = 173; 9%)
• Pregnancy, n = 26
• Family member in study, n = 71
• Unable to read, n = 41a
• Prior participant, n = 34
• Other ineligibility, n = 1
Declined (n = 370; 19%)
Reasons including: does not want
to, too busy, NHS staff/student
(confidentiality concerns), would not
read books, many physical or mental
health problems, moving away
Post-randomisation exclusion (ineligible
at randomisation): n = 5/708
Reasons:
• Pregnancy, n = 3
• Unable to read, n = 2
Post-randomisation exclusion (ineligible
at randomisation): n = 4/708
Reasons:
• Pregnancy, n = 2
• Not a short-term quitter, n = 1
• Ineligible age, n = 1
12-month follow-up
Total completed: n = 611/702 (87%)
CO tested: n = 306/365 (84%)
3-month follow-up
Total completed: n = 655/704 (93%)
3-month follow-up
Total completed: n = 651/703 (93%)
12-month follow-up
Total completed: n = 597/702 (85%)
CO tested: n = 310/360 (86%)
Analysed for primary outcome
(n = 702/704)
Died and excluded from analysis (n = 2)
Analysed for primary outcome
(n = 702/703)
Died and excluded from analysis (n = 1)
Died: n = 2 Died: n = 1
FIGURE 2 Participant flow diagram. a, unable to read – literacy or disability (including dyslexia, learning difficulties
and poor eyesight)= 20, limited English= 19, no further details= 2.
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We randomly allocated 1416 short-term quitters to the intervention and the control group. After
randomisation, four participants in the control group and five in the intervention group were found to be
ineligible because of pregnancy at baseline, inability to read or ineligible age at randomisation. In addition,
three participants in the intervention group and none in the control group withdrew from the study
because of illness or other reasons (these three participants were included in analysis, with the assumption
that they had started smoking again).
The follow-up rate was 93% in both the intervention (651 out of 703) and the control group (655 out of 704),
at the 3-month follow-up. Two participants in the control group and one in the intervention group died before
the 12-month follow-up, and these three participants were excluded from further analyses. The follow-up rate
was 85% (597 out of 702) in the intervention group and 87% (611 out of 702) in the control group at the
final 12-month follow-up (11 months after randomisation). The median interval between the CO verification
before randomisation and the 3-month follow-up was 60 days [mean 60.6 days, standard deviation (SD)
7.6 days], and the mean interval between the CO test before randomisation and the 12-month follow-up was
334 days (mean 335.6 days, SD 11.4 days).
At the final follow-up, 360 participants in the intervention group and 365 in the control group reported
abstinence in the previous 7 days and eligibility for a CO test. Verification tests were carried out for 616 of
these participants, 86% in the intervention and 84% in the control group, while 109 participants declined
or were unable to have the test.
The baseline characteristics of participants
The main demographic characteristics at baseline are presented in Table 3. The participants in the two
groups were comparable at baseline in terms of age, sex, marital status, ethnic origin, education,
employment status, English being the first language and receipt of free prescriptions. The percentage of
participants who were unemployed was 10% and more than half (56%) were in receipt of free prescriptions.
Table 4 shows smoking behaviours before the latest quit attempt. Denominators used for categorical
variables were the number of participants who responded to these questions. The percentage of
participants living with a smoking partner was slightly higher in the control group (29.7%) than in the
intervention group (25.9%). Participants in the intervention and the control group were comparable in
terms of cigarettes per day before quitting, first cigarette after waking up and previous quit attempts.
Most of the participants (89%) had previously attempted to quit smoking at least once and many (27%)
had attempted to quit at least four times. About 80% of participants had managed to sustain at least
4 weeks’ abstinence in their previous longest abstinence attempts and more than 40% had been abstinent
for at least 6 months in their longest attempt (see Table 4).
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TABLE 3 The main demographic characteristics at baseline
Demographic characteristic Intervention (n= 703) Control (n= 704)
Age (years), mean (SD) 47.8 (14.1) 47.9 (13.6)
Sex (female), n (%) 381 (54.2) 360 (51.1)
Marital status, n (%)
Married/living with partner 444 (63.2) 423 (60.1)
Separated/divorced 110 (15.6) 114 (16.2)
Single 118 (16.8) 138 (19.6)
Other/unknown 31 (4.4) 29 (4.1)
Ethnic origin, n (%)
European white 690 (98.2) 695 (98.7)
Other 11 (1.6) 8 (1.1)
Unknown 2 (0.3) 1 (0.1)
English the first language, n (%)
Yes 681 (96.9) 674 (95.7)
No 11 (1.6) 16 (2.3)
Unknown 11 (1.6) 14 (2.0)
Employment status, n (%)
In paid employment 372 (52.9) 368 (52.3)
Unemployed 70 (10.0) 71 (10.1)
Looking after the home 53 (7.5) 51 (7.2)
Retired 144 (20.5) 142 (20.2)
Full-time student 9 (1.2) 8 (1.1)
Other 55 (7.8) 64 (9.1)
Education level, n (%)
Degree or equivalent 109 (15.5) 105 (14.9)
A level or equivalent 123 (17.5) 115 (16.3)
GCSE or equivalent 246 (35.0) 234 (33.2)
Other 89 (12.7) 86 (12.2)
None 129 (18.3) 153 (21.7)
Unknown 10 (1.4) 8 (1.1)
Free prescription, n (%)
Yes 400 (56.9) 392 (55.7)
No 298 (42.4) 299 (42.5)
Unknown 5 (0.7) 13 (1.8)
A level, advanced level; GCSE, General Certificate of Secondary Education.
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The reasons given for quitting were similar in the two groups (Table 5). Participants were allowed to select
more than one reason. Health concern was the most common reason for quitting, including worry about
participants’ own future health (70%), already affected health (55%) or family’s health (33%). Cost
consideration was also a common reason given by participants (48%). Other reasons included ‘smoking
sets a bad example to children’ (37%), ‘because I don’t like being addicted’ (32%) and ‘smoking is
antisocial’ (21%).
Most participants considered that it was extremely or very important to give up smoking (95%) and were
extremely or very determined to give up smoking at this attempt (97%). The majority of participants (83%)
considered that they had an extremely or very high chance of giving up smoking forever at this attempt.
There were no noticeable differences in the perceived importance, stated determination and perceived
chances of giving up smoking between the two groups (Table 5).
TABLE 4 Smoking history at baseline
Smoking history variable Intervention Control
Cigarettes per day before quitting, mean (SD) 19.9 (9.5) 20.4 (10.2)
First cigarette after waking up, n (%) n = 702 n = 703
Within 5 minutes 295 (42.0) 298 (42.4)
6–30 minutes 306 (43.6) 292 (41.5)
> 30 minutes 101 (14.4) 113 (16.1)
Living with a smoking partner 114 of 440 (25.9) 124 of 418 (29.7)
Any previous quit attempts 625 of 702 (89.0) 629 of 704 (89.4)
Number of previous quit attempts, n (%) n = 610 n = 612
One 187 (30.7) 173 (28.3)
Two 171 (28.0) 154 (25.2)
Three 94 (15.4) 112 (18.3)
Four or more 158 (25.9) 173 (28.3)
Longest time managed to stay quit before, n (%) n = 603 n = 603
< 1 week 40 (6.6) 46 (7.6)
1–4 weeks 80 (13.3) 68 (11.3)
> 4 weeks to 6 months 224 (37.2) 225 (37.3)
> 6 months to 12 months 96 (15.9) 111 (18.4)
> 12 months 163 (27.0) 153 (25.4)
DOI: 10.3310/hta19590 HEALTH TECHNOLOGY ASSESSMENT 2015 VOL. 19 NO. 59
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Blyth et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
15
TABLE 5 Stated reasons for quitting and perceived importance, determination and chance of giving up smoking at
this attempt
Quitting variable Intervention Control
Reasons for quitting (multiple reasons allowed), n (%) n = 703 n = 704
Because my health is already suffering 380 (54.1) 393 (55.8)
Because smoking costs too much 341 (48.5) 331 (47.0)
For my family’s health 240 (34.1) 223 (31.7)
Smoking is antisocial 147 (20.9) 145 (20.6)
I am worried about my future health 491 (69.8) 495 (70.3)
Other people are pressurising me to 91 (12.9) 69 (9.8)
Because I don’t like being addicted 228 (32.4) 222 (31.5)
Smoking sets a bad example to children 265 (36.8) 259 (36.8)
Importance of giving up smoking at this attempt, n (%) n = 701 n = 699
Desperately important 344 (49.1) 343 (49.1)
Very important 322 (45.9) 327 (46.8)
Quite important 34 (4.9) 28 (4.0)
Not all that important 1 (0.1) 1 (0.1)
Determination to give up smoking at this attempt, n (%) n = 700 n = 700
Extremely determined 483 (69.0) 470 (67.1)
Very determined 193 (27.6) 214 (30.6)
Quite determined 24 (3.4) 16 (2.3)
Not all that determined 0 (0.0) 0 (0.0)
Chances of quitting for good at this attempt, n (%) n = 701 n = 699
Extremely high 273 (38.9) 271 (38.8)
Very high 305 (43.5) 309 (44.2)
Quite high 117 (16.7) 115 (16.5)
Not very high 5 (0.7) 4 (0.6)
Low 1 (0.1) 0 (0.0)
Very low 0 (0.0%) 0 (0.0%)
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Smoking relapse results
Prolonged carbon monoxide-verified smoking abstinence
The primary outcome was prolonged smoking abstinence (with no more than five cigarettes) from months
4 to 12, and CO-verified at the 12-month follow-up. The proportion of prolonged abstinence was 36.9%
in the intervention group and 38.6% in the control group (Table 6). There was no statistically significant
difference between the intervention and control groups (OR 0.93, 95% CI 0.75 to 1.15).
Secondary smoking outcomes
The 7-day self-report point prevalence of smoking was, on average, 21% at 3 months and 48% at 12 months,
and there were no statistically significant differences between the intervention and control groups (see Table 6).
CO-verified smoking abstinence at 12 months included participants who self-reported smoking abstinence that
was validated by CO tests. The CO-verified smoking abstinence at 12 months was 44%, and again there was
no difference between the two groups. We also calculated continuous CO-validated smoking abstinence from
months 2 to 12, after excluding any self-reported smoking (even only a puff). The continuous smoking
abstinence was 31% in the treatment group and 34% in the control group, and there was no significant
difference between the two groups (see Table 6).
Interactions between treatment effect and patient-level variables
We explored the association between treatment effect and patient-level variables by logistic regression analysis
with interaction terms. Ratio of ORs were used to indicate whether or not the effect of the treatment was
modified by participant characteristics. The treatment effect was not statistically significantly associated with
participant characteristics at baseline (Table 7).
TABLE 6 Smoking relapse results
End point
Intervention,
n/N (%) Control, n/N (%) OR (95% CI); p-value
Smoking abstinence
Primary outcome: prolonged abstinence from
4 to 12 months (CO-validated at 12 months)
259 of 702 (36.9) 271 of 702 (38.6) 0.930 (0.749 to 1.154);
p=0.509
Continuous abstinence from 2 to 12 months
(CO-validated at 12 months)
217 of 702 (30.9) 238 of 702 (33.9) 0.872 (0.697 to 1.091);
p=0.231
CO-validated 7-day smoking abstinence at
12 months
309 of 702 (44.0) 305 of 702 (43.4) 1.023 (0.829 to 1.264);
p=0.830
Smoking relapse
7-day self-reported smoking at 3 months 145 of 703 (20.6) 147 of 704 (20.9) 0.985 (0.761 to 1.274);
p=0.906
7-day self-reported smoking at 12 months 342 of 702 (48.7) 337 of 702 (48.0) 1.029 (0.835 to 1.269);
p=0.789
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Association between smoking abstinence and baseline variables
Smoking abstinence and demographic variables at baseline
The results of logistic regression analysis between smoking abstinence at 12 months (the primary end
point) and demographic variables are shown in Table 8. The smoking abstinence was not statistically
significantly associated with sex, education and receipt of free prescription. However, age was
statistically significantly associated with smoking abstinence at 12 months (p= 0.011). For example,
the prevalence of smoking abstinence was 42% in participants aged ≥ 50 years and 35% in those aged
< 50 years. Marital status was also significantly associated with smoking relapse (p= 0.003). The prevalence
of smoking abstinence was 33% in participants who were single, 30% in those separated or divorced and
41% in people who cohabited. There was also a strong association with employment status (p< 0.001).
Of participants in paid employment, 38% remained smoking free, compared with 35% of participants
looking after the home, 41% of retired people, 26% of unemployed participants and only 18% of
full-time students.
Smoking abstinence at 12 months and smoking-related variables at baseline
Table 9 shows the results of logistic regression analyses to investigate the association between smoking
abstinence at 12 months (the primary end point) and smoking-related variables at baseline. Smoking
abstinence at 12 months was not associated with stated reasons for quitting, stated importance, stated
determinations or perceived chances of staying off cigarette for good (see Table 9).
TABLE 7 Results of logistic regression analyses of interactions between treatment effect and baseline variables
Baseline variable
Ratio of ORs (95% CI); p-value
of interaction
Age 0.994 (0.978 to 1.010); p= 0.448
Sex (1, female; 0, male) 1.364 (0.885 to 2.103); p= 0.160
Education (1, none or GCSE; 0, A level/degree) 1.017 (0.629 to 1.646); p= 0.944
Marital status (1, yes; 0, other)
Married or living with a partner 0.912 (0.581 to 1.433); p= 0.690
Single 1.221 (0.688 to 2.169); p= 0.495
Separated or divorced 1.385 (0.744 to 2.579); p= 0.304
Employment status (1, yes; 0, other)
In paid employment 0.925 (0.600 to 1.426); p= 0.724
Looking after the home 2.127 (0.907 to 4.989); p= 0.083
Retired 1.011 (0.593 to 1.722); p= 0.969
Unemployed 1.533 (0.693 to 3.391); p= 0.291
Free prescription (1, yes; 0, no) 1.052 (0.686 to 1.615); p= 0.816
Stop smoking advisor who recruited quitters: core services vs. other 0.663 (0.390 to 1.128); p= 0.130
Living with a smoking partner (1, yes; 0, no) if married or living with a partner 0.555 (0.297 to 1.039); p= 0.066
Number of cigarettes per day before quitting 0.991 (0.969 to 1.014); p= 0.436
Time of smoking the first cigarette after waking (1, within 5 minutes; 0, ≥ 5 minutes) 1.082 (0.696 to 1.683); p= 0.726
Any previous quit attempt (1, yes; 0, no) 0.868 (0.441 to 1.707); p= 0.681
Longest time managed to stay quit before (1, < 4 weeks; 0, ≥ 4 weeks), among those
with previous attempts
1.243 (0.688 to 2.245); p= 0.471
A level, advanced level; GCSE, General Certificate of Secondary Education.
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TABLE 9 Association between smoking abstinence between 4 and 12 months and smoking-related variables at
baseline: results of logistic regression analysis (with a single independent variable)
Smoking-related variable n OR (95% CI) p-value
Stop smoking advisor: core services vs. other 1404 1.361 (1.043 to 1.774) p= 0.023
Living with a smoking partner (1, yes; 0, no) 856 0.730 (0.536 to 0.995) p= 0.046
Number of cigarettes per day before quitting 1403 0.993 (0.982 to 1.005) p= 0.246
Number of cigarettes per day before quitting
(0, < 10; 1, ≥ 10)
1403 0.606 (0.447 to 0.820) p= 0.001
Time of first cigarette after waking up
Within 5 minutes 1403 1.00 p= 0.005a
6–30 minutes 1.320 (1.042 to 1.673)
> 30 minutes 1.631 (1.186 to 2.244)
Any previous quit attempt (1, yes; 0, no) 1403 0.570 (0.406 to 0.799) p= 0.001
continued
TABLE 8 Association between smoking abstinence at 12 months and baseline demographic variables: results of
univariable logistic regression analysis
Baseline demographic characteristic n OR (95% CI) p-value
Age 1404 1.010 (1.002 to 1.0183) p= 0.011
Sex (1, female; 0, male) 1404 0.960 (0.774 to 1.192) p= 0.712
Free prescription (1, yes; 0, no) 1387 0.861 (0.692 to 1.071) p= 0.179
Educational level
None 1211 1.00 p= 0.744a
GCSE 1.010 (0.744 to 1.372)
A level 1.012 (0.707 to 1.450)
Degree 1.172 (0.813 to 1.691)
Marital status
Single 1402 1.00 p= 0.003a
Married or living with a partner 1.412 (1.052 to 1.894)
Separated or divorced 0.861 (0.584 to 1.269)
Employment status
In paid employment 1404 1.00 p< 0.001a
Looking after the home 0.880 (0.572 to 1.353)
Retired 1.138 (0.860 to 1.505)
Unemployed 0.570 (0.379 to 0.886)
Full-time student 0.356 (0.101 to 1.250)
A level, advanced level; GCSE, General Certificate of Secondary Education.
a Overall p-value (Pearson’s chi-squared test) for categorical data.
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TABLE 9 Association between smoking abstinence between 4 and 12 months and smoking-related variables at
baseline: results of logistic regression analysis (with a single independent variable) (continued )
Smoking-related variable n OR (95% CI) p-value
Number of previous quit attempts
None 1371 1.00 p= 0.001a
One 0.701 (0.479 to 1.027)
Two 0.593 (0.402 to 0.876)
Three 0.581 (0.379 to 0.891)
Four or more 0.445 (0.300 to 0.661)
Longest time managed to stay quit before
None 1355 1.00 p< 0.001a
< 1 week 0.720 (0.422 to 1.228)
1–4 weeks 0.542 (0.341 to 0.861)
> 4 weeks to 6 months 0.406 (0.278 to 0.592)
> 6 months to 12 months 0.702 (0.461 to 1.071)
> 12 months 0.765 (0.519 to 1.128)
Stated important of quitting (from 1, desperately
important, to 4, not all that important)
1397 0.932 (0.775 to 1.122) p= 0.459
Stated determination to quit (from 1, extremely
determined, to 4, not all that determined)
1397 0.878 (0.715 to 1.077) p= 0.212
Perceived chance of successfully quitting (from 1,
extremely high, to 6, very low)
1404 1.000 (0.998 to 1.001) p= 0.765
Stated reasons for quitting
Because my health is already suffering 1404 1.042 (0.838 to 1.294) p= 0.713
Because smoking costs too much 0.882 (0.711 to 1.095) p= 0.256
For my family’s health 0.981 (0.780 to 1.234) p= 0.870
Smoking is antisocial 1.293 (0.995 to 1.681) p= 0.055
I am worried about my future health 1.032 (0.815 to 1.307) p= 0.794
Other people are pressurising me to 1.093 (0.780 to 1.533) p= 0.605
Because I don’t like being addicted 1.141 (0.906 to 1.436) p= 0.262
Smoking sets a bad example to children 0.994 (0.795 to 1.243) p= 0.961
a Overall p-value (Pearson’s chi-squared test) for categorical data.
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Quitters who were treated by specialist level 3 advisors were less likely to return to smoking than those
recruited from other types of Stop Smoking Services (p= 0.023). The prevalence of smoking abstinence
was 39% in quitters from core services, 34% from GP practice and 28% from pharmacies and health
trainers (Figure 3).
Although smoking abstinence at 12 months was positively associated with cohabitating with a partner (see
Table 8), the percentage of smoking abstinence was lower for people living with a partner who smoked than
for those who did not (see Table 9). The percentage of smoking abstinence at 12 months was 36% for
participants living with a smoking partner and 43% for participants living with non-smokers (p= 0.046).
Time until the first cigarette after waking was statistically significantly associated with smoking relapse
(p= 0.001). The percentage of smoking abstinence was 33% in participants who smoked the first
cigarette within 5 minutes after waking up, 40% in participants who had the first cigarette between 6 and
30 minutes after waking up and 45% in those who had the first cigarette more than 30 minutes after
waking up. When the absolute number of cigarettes smoked per day before the current attempt was
examined, there was no statistically significant association between the number of cigarettes per day and
the smoking abstinence at 12 months (p= 0.246). However, smoking abstinence was statistically
significantly higher in participants who smoked fewer than 10 cigarettes per day before quitting (48%)
than in those who smoked 10 or more cigarettes (36%) (p= 0.001).
Previous quit attempt was associated with increased smoking relapse (see Table 9). The smoking
abstinence prevalence at 12 months was 36% in participants with any previous quit attempt and 50% in
participants for whom the current quit attempt was the first quit attempt (p= 0.001). In addition, there
was a tendency that the more previous quit attempts, the higher the risk of smoking relapse at the current
attempts. The percentage of smoking abstinence was 41% in participants who had only one previous
quit attempt, 37% in participants who had two or three previous quit attempts and 31% for those with
four or more previous quit attempts (Figure 4). Among participants who had previous attempts, there
was a clear linear association between smoking abstinence at 12 months and the longest time they had








































FIGURE 3 Smoking abstinence at 12 months by type of stop smoking advisors who recruited quitters.
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FIGURE 4 Smoking abstinence at 12 months and number of previous quit attempts.
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Chapter 4 Process and mediating variables
Educational booklets-related variables
Table 10 shows whether or not participants still had and had read the booklets. At the 3-month follow-up,
89% of the intervention group and 79% of the control group reported receiving the booklets or leaflet.
The difference between the two groups was statistically significant (p< 0.001). The percentage of
participants who reported that they still possessed the booklets was statistically significantly higher in the
treatment group than in the control group at the 3-month (83% vs. 62%) and 12-month follow-ups
(49% vs. 35%).
At the 3-month follow-up, about 70% of the participants reported that they had read the booklets (or the
leaflet) and there was no significant difference between the two groups (p= 0.535). By 12 months, only
27% in the treatment group and 21% in the control group reported having read the booklets or leaflet
between 4 and 12 months, and the difference between the groups was statistically significant (p= 0.005).
TABLE 10 Receiving, possession and reading of the booklets
Booklet-related variable Intervention group Control group p-value
Booklets received at 3 months 628/703 (89.3) 554/704 (78.7) p< 0.001
Still had booklets at follow-up, n/N (%)
At 3 months 580/703 (82.5) 437/704 (62.1) p< 0.001
At 12 months 343/702 (48.9) 242/702 (34.5)
Had read the booklets (reported at follow-up), n/N (%)
2–3 months 495/703 (70.4) 485/704 (68.9) p= 0.535
4–12 months 189/702 (26.9) 144/702 (20.5) p= 0.005
How helpful was the booklet, n/N (%)
Reported at 3 months N= 703 N= 704
Unhelpful/missing 299 (42.5) 304 (43.2) p= 0.805
Somewhat helpful 203 (28.9) 250 (35.5)
Very helpful 201 (28.6) 150 (21.3)
Reported at 12 months N= 702 N= 702
Unhelpful/missing 290 (41.3) 294 (41.9) p= 0.829
Somewhat helpful 215 (30.6) 259 (36.9)
Very helpful 197 (28.1) 149 (21.2)
p-values were based on Pearson chi-squared tests for categorical data.
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Participants in the intervention group reported spending more time reading the booklets than did control
group participants (Figure 5). The percentage of participants who spent more than 30 minutes on reading the
booklets was 43% in the intervention group and only 9% in the control group by the 3-month follow-up, and
it was 18% and 7% respectively between 4 and 12 months. In the intervention group, 58% of participants
reported they had read more than one of the eight booklets by 3 months and only 20% had done so between
4 and 12 months (Figure 6). The percentage of participants who read all eight booklets in the intervention
group was 31% by 3 months and 10% between 4 and 12 months.
The percentage of participants who considered the booklets unhelpful (or unclear) was similar between
the treatment and control group (see Table 10). Compared with the control group, the percentage
of participants who considered the booklets very helpful was somewhat higher in the intervention group
(28% vs. 21% at 12 months), while the percentage of those who considered the booklets somewhat
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FIGURE 5 Time spent on reading the educational booklets. (a) Between 2 and 3 months; (b) between 4 and
12 months. Note, percentages have been rounded.
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We asked the participants if reading the booklets meant that they were more able to identify situations in
which the risk of relapse was higher. The proportion of participants reporting that they knew much more
about which situations might lead to relapse was 26% in the intervention group and 18% in the control
group at the 3-month follow-up, and 25% and 21% respectively at the 12-month follow-up. The
proportion of participants who reported that reading the booklets taught them no more than they knew
already was lower in the treatment group at the 3-month follow-up (48% vs. 53%; p= 0.04), but there
was no difference between the groups at the 12-month follow-up (Table 11). Between the treatment and
control group, there were no significant differences in the proportion of participants who reported that
reading the booklets taught them more about ways to handle urges to smoke at 3 and 12 months
(see Table 11).
Coping strategies and activities
When participants were asked what things they knew they could do to cope with urges to smoke, the
percentage of all participants who reported one or more strategies was 87% at the 3-month follow-up
and 66% at the 12-month follow-up, and there was no significant difference between the two groups
(Table 12). The number of coping strategies that participants reported they knew is shown in Figure 7,
which reveals no significant difference between the groups at both the 3-month follow-up (p= 0.798) and
the 12-month follow-up (p= 0.453).
Behavioural coping strategies were more frequently reported than mental scoping skills. At the 3-month
follow-up, the percentage of participants who reported at least one behavioural coping strategy was 67%,
compared with 41% who reported at least one mental coping strategy. Only 21% of participants reported
































































FIGURE 6 Number of booklets that participants had read. (a) Between 2 and 3 months; (b) between 4 and
12 months.
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TABLE 11 Effect of booklets on knowledge about relapse risky situations and ways of handling urges
Knowledge about risky situations and ways of
handling urges Intervention group Control group p-value
Knew more about relapse risky situations, n (%)
Reported at 3 months N= 703 N= 704
No/not sure 335 (47.7) 374 (53.1) p= 0.040
A little more 187 (26.6) 204 (29.0)
Much more 181 (25.8) 126 (17.9)
Reported at 12 months N= 702 N= 702
No/not sure 340 (48.4) 341 (48.6) p= 0.957
A little more 180 (25.6) 212 (30.2)
Much more 182 (25.9) 149 (21.2)
Knew more about ways of handling urges, n/N (%)
Reported at 3 months N= 703 N= 704
No/not sure 342 (48.7) 373 (53.0) p= 0.104
A little more 193 (27.5) 193 (27.4)
Much more 168 (23.9) 138 (19.6)
Reported at 12 months N= 702 N= 702
No/not sure 344 (49.0) 346 (49.3) p= 0.915
A little more 190 (27.1) 220 (31.3)
Much more 168 (23.9) 136 (19.4)
p-values were based on Pearson chi-squared test for comparing no/not sure with any more (including a little more and
much more).
TABLE 12 Coping strategies that participants knew and attempts to handle urges
Coping strategy Intervention group Control group p-value
Knew at least one thing that could be done to handle urges, n/N (%)
At 3 months 608/703 (86.5) 611/704 (86.8) p= 0.867
At 12 months 447/702 (63.7) 460/702 (65.5) p= 0.468
Knew at least one behavioural activity that could be used to handle urges, n/N (%)
At 3 months 465/703 (66.2) 470/704 (66.8) p= 0.807
At 12 months 325/702 (46.3) 339/702 (48.3) p= 0.454
Knew at least one mental exercise that could be used to handle urges, n/N (%)
At 3 months 303/703 (43.1) 275/704 (39.1) p= 0.124
At 12 months 201/702 (28.6) 194/702 (27.6) p= 0.678
Knew both behavioural and mental things that could be used to handle urges, n/N (%)
At 3 months 160/703 (22.8) 134/704 (19.0) p= 0.086
At 12 months 79/702 (11.3) 73/702 (10.4) p= 0.606
Ever attempted to do something to cope with urges, n/N (%)
At 3 months 580/703 (82.5) 585/704 (83.1) p= 0.768
At 12 months 420/702 (59.8) 431/702 (61.4) p= 0.548
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People who reported reading the booklets tended to report knowing more strategies to cope with urges
(Figure 8). For example, at the 12-month follow-up, the percentage of participants who knew one or more
coping strategy was 83% in those who had read the booklets and 59% in those who had not.
About 83% of all participants by 3 months and 61% between 4 and 12 months reported enacting a
strategy to handle urges to smoke, with no significant differences between groups (see Table 12).
The percentage of participants who tried to do something was positively associated with any booklet
reading, knowing more about risky situations and knowing more about ways of handling urges (Figure 9).
However, there were no significant differences in attempts to do something to handle urges between
reading of one and more booklets, and between knowing little more and much more about risky







































































FIGURE 7 Percentage (%) of participants who reported things they knew to handle urges, by number of things







































FIGURE 8 Reporting of coping strategies and booklet reading.
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Mediating variables and smoking abstinence at 12 months
The mediating variables were not associated with the educational materials used in general, and the analyses
of associations between mediating variables and the smoking outcome were therefore conducted without
taking into account participants’ treatment group. The results of the logistic regression analyses to investigate
the association between smoking abstinence at 12 months and mediating variables are presented in Table 13.
Smoking abstinence at 12 months was less common in people who had not read booklets by 3 months than in
those who did, although there was no significant association between smoking abstinence and booklet
reading between 4 and 12 months (p= 0.493). The percentage of smoking abstinence at 12 months was 41%
in participants who read the booklets, compared with 30% for those who did not, by the 3-month follow-up,
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FIGURE 9 Ever tried to do something to handle urges and booklet reading, and changes in knowledge on risky
situations and ways of handling urges.
TABLE 13 Association between smoking abstinence between 4 and 12 months and mediating variables: results of
univariable logistic regression analyses
Mediating variable
OR (95% CI); p-value
2–3 months 4–12 months
Any reading of booklets 1.625 (1.274 to 2.072); p< 0.001 1.092 (0.849 to 1.406); p= 0.493
Time spent on reading booklets 1.073 (1.001 to 1.151); p= 0.048 1.020 (0.943 to 1.104); p= 0.615
Number of booklets being looked at 1.035 (0.996 to 1.075); p= 0.080 1.047 (0.989 to 1.109); p= 0.117
Know more about risky situations 1.186 (1.037 to 1.356); p= 0.013 1.484 (1.299 to 1.696); p< 0.001
Know more about ways of handling urges 1.146 (1.002 to 1.310); p= 0.046 1.462 (1.276 to 1.675); p< 0.001
No. of coping strategies reported 1.076 (0.989 to 1.170); p= 0.088 1.375 (1.246 to 1.517); p< 0.001
Ever tried to do something to handle urges 1.730 (1.275 to 2.347); p< 0.001 3.109 (2.445 to 3.954); p< 0.001
OR < 1 indicates that smoking replace rate is reduced. Time spent on reading booklets was an ordinal variable (0, no
reading; 1, 1–10 minutes; 2, 10–29 minutes; 3, 30–59 minutes; 4, 60–119 minutes; 5, ≥ 120 minutes).
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There was no clear dose–response relationship among participants who had read any booklets (Figures 11
and 12). The results of multiple logistic regression analyses are shown in Table 14. Smoking abstinence at
12 months was statistically significantly associated with booklet reading between 2 and 3 months
(p< 0.001), but not with booklet reading between 4 and 12 months (p= 0.759), which indicated that the
use of education materials at an early stage may be important. After including the variable of any booklet
reading in analyses, there was no significant association between smoking abstinence and any reading of
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FIGURE 11 Smoking abstinence at 12 months by time spent on reading booklets.
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Smoking abstinence at 12 months was higher in participants who reported knowing more about risky
situations or knowing more ways to handle urges because they had read the booklets (see Table 13).
However, there was no significant difference in smoking abstinence at 12 months between knowing a
little more and knowing much more (Figures 13 and 14). The proportion of smoking abstainers was higher
in those who reported knowing more strategies to cope (see Table 13), although there was no clear
dose–response relationship between knowing only one and knowing more than one strategy (Figure 15).
Participants who reported doing something to handle urges to smoke were less likely to relapse by
12 months than were people who had no strategy to cope with urges (see Table 13). Of participants who
reported that they had tried to handle urges between 4 and 12 months, 48% remained smoking free by
12 months, compared with 23% of those who did not report a strategy (Figure 16). The difference in
smoking abstinence between no attempt and any attempts from 4 to 12 months (48% vs. 23%) was
greater than between no attempt and any attempts from 2 to 3 months (40% vs. 28%).
Further analysis was conducted by using the following categories: participants who reported no strategy to
handle urges, participants who reported using strategies only at the 3-month follow-up, participants who
reported strategies only at the 12-month follow-up and participants who reported using strategies at both
the 3-month and the 12-month follow-ups (Table 15). The proportion of smoking abstainers was lowest
among participants who reported using no strategies or attempts to control urges at all (19%) and highest
among participants who had attempted by the 3-month and 12-month follow-up (48%). Participants who
reported any attempts by only the 3-month follow-up had a smoking relapse rate slightly higher than
those who reported no attempts at all (24% vs. 19%). These results indicated that the prevention of
smoking relapse needs continued efforts to do something to handle urges.
TABLE 14 Smoking abstinence and booklet reading: results of multiple logistic regression analyses
Booklet reading
OR (95% CI); p-value
2–3 months 4–12 months
Any reading (binary) 1.850 (1.323 to 2.587); p< 0.001 1.083 (0.650 to 1.806); p= 0.759
Time on reading (ordinal) 0.931 (0.827 to 1.049); p= 0.240 0.927 (0.778 to 1.103); p= 0.392
Number of booklets read 1.012 (0.960 to 1.068); p= 0.650 1.077 (0.989 to 1.174); p= 0.088
Dependent variable was smoking (7 days, CO-verified) at the final follow-up interview. Independent variables were based
on participant reporting at 3-month and 12-month follow-up interviews. OR < 1 indicates that smoking replace rate is
reduced. Time spent on reading booklets was an ordinal variable (0, no reading; 1, 1–10 minutes; 2, 10–29 minutes;


































FIGURE 13 Smoking abstinence at 12 months by knowing more about risky situations.
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4 – 12 months
FIGURE 16 Smoking abstinence at 12 months and attempts to do something to handle urges.
TABLE 15 Percentage of smoking abstinence at 12 months by attempts to do something to handle urges
Attempt n/N Smoking abstinence, % (95% CI)
No attempt at all 30/159 18.9 (13.5 to 25.8)
Only by 3-month follow-up 95/394 24.1 (20.1 to 28.6)
Only by 12-month follow-up 37/83 44.6 (34.1 to 55.6)
At both 3- and 12-month follow-up 368/768 47.9 (44.4 to 51.5)





































































FIGURE 15 The number of coping strategies known and smoking abstinence at 12 months.
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Chapter 5 Use of additional smoking cessation
interventions
Any use of additional cessation interventions
At the 3- and 12-month follow-up interviews, participants were asked whether or not they had used
smoking cessation aids following their initial use of the NHS Stop Smoking Service at baseline. There were
no significant differences in the use of additional stop smoking interventions between the treatment and
the control groups (Table 16).
TABLE 16 Use of additional stop smoking interventions during the follow-up period, by treatment conditions
Additional stop smoking interventions Treatment group Control group p-value
Any contacts with Stop Smoking Clinics, n/N (%)
During 2–3 months 406/703 (57.8) 434/704 (61.7) p= 0.136
During 4–12 months 105/702 (15.0) 107/702 (15.2) p= 0.881
Any use of stop smoking medications, n/N (%)
During 2–3 months 510/703 (72.6) 532/704 (75.6) p= 0.196
During 4–12 months 155/702 (22.1) 180/702 (25.6) p= 0.118
Any use of varenicline (Champix®, Pfizer), n/N (%)
During 2–3 months 282/703 (40.1) 275/704 (39.1) p= 0.687
During 4–12 months 38/702 (5.4) 41/702 (5.8) p= 0.728
Any use of bupropion (Zyban®, GSK), n/N (%)
During 2–3 months 1/703 4/704 –a
During 4–12 months 2/702 2/702 –a
Any use of NRT products, n/N (%)
During 2–3 months 244/703 (34.7) 267/704 (37.9) p= 0.210
During 4–12 months 122/702 (17.4) 143/702 (20.4) p= 0.152
Use of other educational materials, n/N (%)
During 2–3 months 124/703 (17.6) 142/704 (20.2) p= 0.225
During 4–12 months 68/702 (9.7) 62/702 (8.8) p= 0.581
Any use of electronic cigarettes, n/N (%)b
During 2–3 months 18/703 (2.6) 19/704 (2.7) p= 0.871
During 4–12 months 43/702 (6.1) 56/702 (8.0) p= 0.175
NRT, nicotine replacement therapy.
a Statistical test was not conducted for the use of bupropion because the number of events was too small.
b The use of electronic cigarettes was not explicitly listed among other smoking cessation treatments in the follow-up
questionnaire and was recorded only if participants mentioned they had used it.
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In total, 60% of participants contacted an NHS Stop Smoking Clinic in the 2 months after they were
proven abstinent at week 4; 15% did so from months 4 to 12. Most people (74%) continued using
cessation medication in the 2 months after randomisation; 24% did so between 4 and 12 months after
randomisation. Specifically, 40% of participants used varenicline and 36% used nicotine replacement
therapies (NRTs) by the 3-month follow-up. Only 6% of participants used varenicline and 19% used NRT
between 4 and 12 months after randomisation. In general, the use of cessation aids decreased over time.
The exception is the use of electronic cigarettes, which increased from 2.6% between 2 and 3 months
to 7.1% between 4 and 12 months.
Additional cessation treatments and smoking abstinence at
12 months
Table 17 compares the results of prolonged abstinence between 4 and 12 months by the use of additional
cessation interventions. In general, the use of cessation interventions between 2 and 3 months was
associated with increased smoking abstinence by 12 months, while the use of cessation treatments
between 4 and 12 months was associated with a lower percentage of prolonged smoking abstinence.
TABLE 17 Association between prolonged smoking abstinence (during months 4 to 12) and additional smoking
cessation interventions
Additional stop smoking interventions Not used Used p-value
Any contacts of Stop Smoking Clinics, n/N (%)
During 2–3 months 176/565 (31.2) 354/839 (42.2) p< 0.001
During 4–12 months 478/1192 (40.1) 52/212 (24.5) p< 0.001
Any stop smoking medications, n/N (%)
During 2–3 months 106/363 (29.2) 424/1041 (40.7) p< 0.001
During 4–12 months 440/1069 (41.2) 90/335 (26.9) p< 0.001
Any use of varenicline, n/N (%)
During 2–3 months 310/847 (36.6) 220/557 (39.5) p= 0.273
During 4–12 months 520/1325 (39.3) 10/79 (12.7) p< 0.001
Any use of NRT, n/N (%)
During 2–3 months 318/894 (35.6) 212/510 (41.6) p= 0.026
During 4–12 months 450/1139 (39.5) 80/265 (30.2) p= 0.005
Any use of bupropion, n/N (%)
During 2–3 months 529/1399 (37.8) 1/5 –a
During 4–12 months 529/1400 (37.8) 1/4 –a
Use of other educational materials, n/N (%)
During 2–3 months 412/1138 (36.2) 118/266 (44.4) p= 0.013
During 4–12 months 467/1274 (36.7) 63/130 (48.5) p= 0.008
Any use of electronic cigarettes, n/N (%)b
During 2–3 months 517/1368 (37.8) 13/36 (36.1) p= 0.837
During 4–12 months 503/1305 (38.5) 27/99 (27.3) p= 0.026
a Statistical test was not conducted for the use of bupropion because the number of events was too small.
b The use of electronic cigarettes was not explicitly listed among other smoking cessation treatments in the follow-up
questionnaire and was recorded only if participants mentioned they had used it.
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Of the participants who contacted stop smoking advisors, 42% achieved prolonged smoking abstinence
during the first 2 months after randomisation, compared with 31% of those without such contact
(p< 0.001). However, only 25% of participants who contacted stop smoking advisors remained abstinent
between 4 and 12 months, compared with 40% of participants who did not have such contact (see Table 17).
These results indicated that additional smoking cessation treatments were more likely to be used during
months 4–12 by relapsed participants than by those who were still smoking free.
The numbers of participants exhibiting 7-day point smoking abstinence (CO-validated) at 12 months by
additional cessation treatments are shown in Table 18. The point smoking abstinence at 12 months tended
to be slightly higher among participants who contacted stop smoking advisors (49% vs. 43%) or used any
cessation medications (46% vs. 43%) during months 4–12, although the difference was statistically
non-significant (see Table 18). Clearly, the use of additional cessation treatments between 4 and 12 months
helped some relapsed participants quit again before the 12-month follow-up.
TABLE 18 Association between validated 7-day smoking abstinence at 12 months and additional smoking
cessation interventions
Additional stop smoking interventions Not used Used p-value
Any contacts of Stop Smoking Clinics, n/N (%)
During 2–3 months 207/565 (36.6) 407/839 (48.5) p< 0.001
During 4–12 months 510/1192 (42.8) 104/212 (49.1) p= 0.090
Any stop smoking medications, n/N (%)
During 2–3 months 122/363 (33.6) 492/1041 (47.3) p< 0.001
During 4–12 months 460/1069 (43.0) 154/335 (46.0) p= 0.344
Any use of varenicline, n/N (%)
During 2–3 months 362/847 (42.7) 252/557 (45.2) p= 0.355
During 4–12 months 577/1325 (43.6) 37/79 (46.8) p= 0.567
Any use of NRT products, n/N (%)
During 2–3 months 364/894 (40.7) 250/510 (49.0) p= 0.003
During 4–12 months 495/1139 (43.5) 119/265 (44.9) p= 0.669
Any use of electronic cigarettes, n/N (%)a
During 2–3 months 601/1368 (43.9) 13/36 (36.1) p= 0.350
During 4–12 months 580/1305 (44.4) 34/99 (34.3) p= 0.051
Use of other educational materials, n/N (%)
During 2–3 months 477/1138 (41.9) 137/266 (51.5) p= 0.005
During 4–12 months 540/1274 (42.4) 74/130 (56.9) p= 0.001
a The use of electronic cigarettes was not explicitly listed among other smoking cessation treatments in the follow-up
questionnaire and was recorded only if participants mentioned they had used it.
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Chapter 6 A qualitative process evaluation of use
of self-help materials for relapse prevention within
the context of the SHARPISH trial
This chapter reports on qualitative data collected as part of the trial follow-up questionnaire, andin-depth data collected as part of a further qualitative substudy. Process evaluation of randomised
controlled trials involving qualitative methods is increasingly recognised as important to informing and
assisting with interpretation of trial outcomes.40,41 In the case of the Self-Help And Relapse Prevention In
Smoking for Health (SHARPISH) trial, we sought to explore patient-reported experiences of using the
self-help materials (the control leaflet or the intervention booklets), focusing on the response of individuals
to the intervention being tested.42 This has enabled us to understand the variations in ways in which the
materials were actually used and the extent to which the materials were engaged with.
Methods
A thematic content analysis of open-ended responses to questionnaire follow-up questions collected at
3 months and 12 months was undertaken. A further in-depth qualitative substudy was undertaken across
three core areas of recruitment:
l study 1a: qualitative interviews with participants who had and had not relapsed in the control and
intervention arms of the SHARPISH trial at 12-month follow-up
l study 1b: a focus group with a selected sample of smoking cessation professionals
l study 1c: focus groups with trial participants.
For study 1a, a purposive sample of participants already recruited to the SHARPISH trial was selected. The
sample aimed to achieve maximum variation across trial participants by accessing demographic data collected
as part of the trial to ensure that there was a spread of representation. A sample size of approximately
40 participants was the target recruitment. Study 1b recruited a convenience sample of professionals to take
part in a focus group. A focus group was undertaken with core service staff (specialist advisors), who recruited
73% of the participants to the trial. Study 1c purposefully recruited a further subsample of trial participants to
take part in focus groups. The aim was to sample approximately 20 patients in total, consisting of four focus
groups of approximately five patients per group.
The interview guide was developed in consultation with lay representatives, and the focus group topic
guide was developed following analysis of the qualitative interview data.
There were two key aims of the analysis of the interview and focus group data:
1. to give an explanatory context for trial findings
2. to explore patient experience of use of self-help materials.
A thematic content analysis43 approach was used to code all data in transcripts that was relevant to exploring
the use of the self-help booklets and the leaflet. Transcripts were read through line by line, and sections of
text were coded for meaning. Codes were mostly descriptive, but some interpretative codes were assigned.
Following a grounded theory approach,44 initial open coding was organised into higher-level (axial) coding,
and interpretations reported here are made on the basis of the axial coding scheme (Figure 17). Coding was
undertaken primarily by one researcher (CN). Two independent researchers undertook independent coding on
a total of 25% of the transcripts. Coding was discussed at team meetings until consensus on categories was
reached. Final analysis was presented to lay representatives for verification and feedback. In this chapter, italic
text has been used to show coding that arose from the interviews.
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Data from studies 1b and 1c were used to triangulate the qualitative data and assist with validation of and
consensus on the qualitative analysis. Focus groups were also used as an opportunity to feed back trial
findings to participants and stop smoking professionals, and to gather feedback and views on the
trial outcome.
Analysis of trial open-ended questionnaire data
All available qualitative comments to 12-month follow-up questionnaire responses were extracted.
Responses were coded in answer to the questions:
1. Do you have any other comments about the booklet(s)?
2. What were the main things you learnt from reading the booklet(s)?
Comments were initially coded into considerations of the booklets as being helpful or as being generally
unhelpful. A total of 426 responses were coded under the helpful code, in comparison with a total of 284
coded as unhelpful. This coding includes those randomised to both the intervention and control groups, so
in the context of this analysis participants were commenting on the written material received (i.e. either
the control leaflet or the intervention booklets). Given this, we see that just over half of the trial sample
(710 people) gave a further open-ended comment about the self-help materials received and, of those,
60% considered the written material to be helpful.
This corresponds well with trial process mediating variables, finding that those who reported reading the
intervention booklets self-reported higher levels of strategies for coping with urges and had lower relapse
rates than those who reported not having read the booklets in the intervention group.
Among those answering the open-ended question inviting further comment on the booklets who
indicated that they had found them unhelpful, a total of 142 participants indicated that they were
unaware of or were unable to recall the content of the self-help information received. A smaller but
possibly important section of the sample (68 participants) suggested that the written materials did not
contain any new or novel information that they had not heard before.
Study 1a: qualitative interviews with individual trial participants
Demographics
In total, 43 qualitative interviews were undertaken as part of study 1a (Table 19). Interviews were audio-
recorded and transcribed in full. The recruitment target was exceeded because of purposive sampling to
ensure coverage of participants across all trial areas.
TABLE 19 Summary of sample size across the sample frame of key sampling characteristics
Smoking status Intervention Control
Abstinent 15 11
Relapsed 8 9
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1. Age (three groups: older, mid, younger. Cut-off points based on trial age distribution):
i. older, > 55 years, n= 18
ii. mid, 30–54 years, n= 23
iii. younger, 18–29 years, n= 2.
2. Sex:
i. women, n= 23
ii. men, n= 20.
3. Employment status:
i. employed or self-employed, n= 25
ii. retired, n= 9
iii. unemployed, n= 2
iv. ‘other’, n= 7.
4. Level of prior nicotine dependence (self-report of number of cigarettes smoked per day at trial baseline):
i. heavy,≥ 30 per day, n= 3
ii. moderate,= 11–29 per day, n= 29
iii. light,≤ 10 per day, n= 11.
5. History of smoking (number of prior quit attempts):
i. one or two, n= 20
ii. three or more, n= 21
iii. never tried before, n= 1.
iv. (one person missing data).
6. Use of pharmacological interventions (NRT, varenicline – self-report at baseline) – all used something
apart from one person (willpower alone).
7. Service attendance (core specialist Stop Smoking Service or other community-based stop
smoking advisor:
i. core service, n= 31
ii. other community-based advisor, n= 12.
8. Area (recruitment area):
i. Norfolk, n= 37
ii. Hertfordshire, n= 3
iii. Suffolk, n= 2
iv. Lincolnshire, n= 1.
This purposive sample was representative of the study population as a whole in terms of secondary
sampling characteristics: gender, employment, use of pharmacological interventions, service attendance
and area of recruitment. We specifically sought to oversample from those who reported continued
abstinence at follow-up, since this was the primary trial outcome studied.
There was slight over-representation of older people (> 55 years), lighter smokers (≤ 10 per day) and
those with a greater number of prior quit attempts (≥ 3) – probably a function of age.
QUALITATIVE PROCESS EVALUATION
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Findings
Of the 43 interviews fully transcribed, 23 participants were recruited from the trial intervention group and
were probed during interviews around their use of the self-help booklets. Questions were open ended to
be non-leading, but prompts asked participants to think about how they had used the booklets as well as
their general impressions of them, their perceived usefulness and suggestions for possible improvements
to the materials.
Participants gave general comments that were classified as broadly positive or negative. Further comments
were coded to explore perceptions of the content, perceived impact, use and possible improvements
related to the booklets (see Figure 17).
Content of Forever Free booklets
There were some very positive comments about the design and content of the booklets. Specifically
mentioned without prompting was information given on the physiology of stopping smoking and the
physical process of craving. In addition, participants spontaneously volunteered that identifying smoking
triggers and suggestions for distraction strategies were useful when smoking cravings were felt.
One participant discussed remembering the information given about the physical impact of stopping
smoking, and how he found this useful and motivating:
Patient: It was a glance through and there was one bit that I did read which I found quite interesting
was the effects when you stop smoking . . . what happens after 1 day . . . 2 days after a week.
Interviewer: Was it like sort of a chart?
Patient: Like a chart sort of thing.
Interviewer: Yes.
Patient: And it goes down you know after I forget what it was now but after so many days nicotine
leaves the body . . . um, and then sense taste and smell starts to improve . . . and then it gets to the
point of uh your chances of a heart attack become the same as a non-smoker . . . and after so long,
you know, and that’s a target to go for.
Participant number 0766: male, aged 54 years, abstinent, intervention group
The frequency of coding around this area, and other more technical aspects of stopping smoking, seemed
to suggest that participants valued scientific information that reaffirmed their reasons for stopping
smoking, and provided motivation to keep maintaining abstinence for a certain period of time (e.g. to
reach the point at which chances of a heart attack become the same as for a non-smoker). Others
commented specifically on concrete and practical content of the booklets that they felt able to implement
themselves, such as the suggestions for distraction strategies:
Patient: I wouldn’t say there was any one – thing – only, only the, the, the – if you, you start getting
the urge then to try and keep yourself, erm – keep your, your mind occupied and, and [coughs] and
so to divert it away from – erm from just thinking about cigarettes.
Interviewer: Yeah – so when you had an urge, you know or when you felt like you really wanted to
smoke, you used some of what it suggested? . . .
Patient: As I say the drinking, the drinking plenty of, something I never used to do, drink plenty of
water and . . . and just general keep try, general keep me, keep myself a bit busy.
Participant number 0677: male, aged 75 years, relapsed, intervention group
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Participants generally felt that the booklets were ‘well designed’ and ‘authoritative’. The first booklet,
giving an overview of relapse prevention, was particularly mentioned more frequently than the other
booklets. The booklet focusing on weight and controlling weight gain was also mentioned. However,
some participants felt that the booklets were ‘overly simplistic or contained too much information’. Others
could not remember specific details about the booklets, and 6 of the 23 intervention group participants
reported that they felt that the booklets contained no new information – ‘nothing that I didn’t
know already’:
What was in the booklets is . . . it was more geared up to somebody that, but then I still think that
people who are smoking know all of the coping strategies to get through it and things, maybe it just
reiterates it a bit more, but . . . it was teaching your granny to suck eggs.
Participant number 0748: female, aged 39 years, abstinent, intervention group
This point was specifically mentioned in the context of the advice that had already been received via the
Stop Smoking Service:
Most – as I said – I’d already received from [name] or from my advisor.
Participant number 0702: male, aged 33 years, relapsed, intervention group
Perceived impact
There was a mixture of responses as to the perceived longer-term impact of the booklets. Some reported
that the booklets were depressing or actually worked counter to their aim by reminding the participant
of smoking:
Patient: I’ll be very honest and I’ll say after I read the first, I started to read it, I got in, er I flicked
through a few books.
Interviewer: Yeah, yeah.
Patient: I got depressed.
Interviewer: Really.
Patient: So yeah, I, I felt like a cigarette after I read it.
Participant number 0666: male, aged 65 years, abstinent, intervention group
However, 12 of the 23 intervention group participants reported retaining the booklets, with a view to
‘keep referring back’ to them. Others who had relapsed ‘planned to use the booklets for a future
quit attempt’.
Many participants reported ‘sharing them with others’. One focus group participant also corroborated this,
reporting that she referred to the booklets in her own work within the health service and found it
particularly useful to signpost patients towards sections of the booklets of relevance to them, such as the
information on weight loss or dietary changes. Twelve of the intervention group participants reported this,
saying that they allowed partners or family members to read them.
Patient: Uh so I read that quite seriously, the others I glanced through, my son was up and he said
‘what are you doing dad?’ and I told him and he said ‘oh I’ll have a go at them’.
Interviewer: Yes.
Patient: So he took them . . . so I didn’t really read through them very much but he took them and
he stopped.
Participant number 0720: male, aged 69 years, abstinent, intervention group
QUALITATIVE PROCESS EVALUATION
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Four participants reported quite forcefully that the booklets were ‘not for me’. The data here gave a sense
that, while the booklet format and content may be particularly suited to some people, there were others
for whom the booklets were definitely not suited:
It wasn’t pitched too high or too low, I think it was just right for somebody, but personally not for me,
and in fact that’s why I only read the first couple I thought ‘well . . . if they’re all like that’ . . . you
know, not for me, but they’re still in the cupboard, I’ve not just ditched them.
Participant number 0748: female, aged 39 years, abstinent, intervention group
Use of the booklets
As with the perceived impact, participants described different degrees of engagement. Some participants
reported ‘flicking through the booklets, not reading all the booklets’ or reading them once but never
referring back to them:
Yeah I was given the booklets, yeah I read through most of them but ummm, yeah, and then they
were put out of the way, and I haven’t looked at ‘em since, to be honest! [Laughs.]
Participant number 0638: male, aged 59 years, abstinent, intervention group
However, 12 of the 23 intervention group participants reported that they did refer back to the booklets as
a strategy to help them cope with urges to smoke:
Patient: And it’s basically, if I come across a, you know, a weak, weak moment or whatever . . .
Interviewer: You would look at the booklets?
Patient: Yeah, yeah, yeah I would go through yes . . . almost definitely, distinctly feel, as I say, I’ll see
how I get on this weekend, but I, er, definitely think I’ll, er, I’ll have to, I’ll need to refer back to them
I think . . .
Interviewer: Yeah, yeah. And did you keep looking at them every day, or did you put them aside for a
few weeks and come back to them?
Patient: No, I, er, I wouldn’t say I looked at them every day, I, two or three times, at least two or three
times a week, I would look through them.
Participant number 0677: male, aged 75 years, relapsed, intervention group
Others reported referring back to the booklets to reaffirm their motivation to stay abstinent, and to praise
themselves by reminding themselves of how long it had been since the initial quit attempt:
But then obviously I went back to them and then obviously . . . yes, I already had it open because, yes I
did, cos every now and then I would I’d just look at it just to remind myself that, you know, now you
know where I am now, where I was even like 6 months ago . . .
Participant number 0723: female, aged 45 years, abstinent, intervention group
Suggestions for possible improvement to the materials
Many other suggestions were given by individual participants for possible ways in which the self-help
booklets might be improved, including those listed below:
l an abbreviated version/needs to be more succinct
l addressing smoking marijuana
l content needs to be more targeted towards certain age groups
l information would be better as a ‘slow drip’
l more graphic or explicit material on the harms of smoking
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l more information on downsides of NRT
l more information on health consequences
l more information on positive health improvements of staying stopped
l more information on NRT and other stop smoking aids
l more information on side effects of stopping smoking
l more visual impact
l need information on electronic cigarettes
l would have been good to have had them at first contact with stop smoking advisor
l electronic booklets would be preferable, as could flick to relevant information easily
l would be good as PDFs (portable document format files) for an e-book reader
l would use a mobile phone app
l would use an app
l would use the internet for support booklets.
Frequent suggestions were for electronic versions of the self-help booklets in PDF format, as an app or
available as part of internet-based support. Suggestions about the timing of the information were also
illuminating, as some reported feeling overwhelmed by the quantity of information received all at once or
that the information would be better received as a ‘slow drip’, delivered over a longer period of time.
These comments link to other comments around the desire for more ‘succinct’ or ‘abbreviated versions’ of
the booklets.
Use of the control leaflet
For comparison between the trial groups, participants from the control group were also asked about their
use of the self-help relapse prevention leaflet Learning to Stay Stopped. Comments in relation to this
leaflet were, unsurprisingly, briefer. However, revealingly, many of the inductively derived codes were
similar to the coding reported above for the intervention booklets. In terms of the leaflet content,
participants generally reported that the leaflets did not contain anything they had not already learnt
themselves, possibly via their stop smoking advisor:
To be honest, I’ve been trying to stop for so long, to be honest, it didn’t have anything in it that I
didn’t already know.
Participant number 0697: female, aged 46 years, relapsed, control group
Although there was a roughly even split among control group participants between those who generally
reported that they found the leaflet ‘useful’ and those who found it ‘not useful’, many of the more in-
depth comments were more negative, and there was a perception that the information was not relevant
to me:
Um, I wouldn’t say to me, personally, they were useful . . . um, I feel they’d be much more helpful to
somebody younger or somebody that hasn’t smoked for as long.
Participant number 0779: female, aged 44 years, relapsed, control group
Many comments about use of the control leaflet related to the fact that the leaflet was not frequently
referred back to, or was read once but not again:
I couldn’t pick out I really couldn’t, yes it’s just it’s one of those, one of those pieces of literature you
read . . . and you digest and then you think it’s not, it doesn’t interest me what it’s saying, so you just
put it out of your mind, so to be honest I didn’t actually gain anything. I didn’t go back to it. I didn’t
do anything with it.
Participant number 0727: female, aged 53 years, abstinent, control group
QUALITATIVE PROCESS EVALUATION
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Study 1b: feedback from professionals
A short group discussion was held with cessation professionals to feed back initial study findings. Twelve
stop smoking advisors attended this team meeting (including advisors and team leaders/managers). This
brief informal feedback meeting was used as an opportunity to gain feedback from stop smoking
professionals on the trial findings and to glean views on the self-help materials used as part of the trial.
The stop smoking professionals commented that they liked the booklets and that they looked
professionally produced. Booklets were passed around at the group discussion but no detailed comments
were given with regard to the specific content of the booklets.
Professionals reported that they felt a slight sense of disappointment that the trial had found that the booklets
were not effective. However, they were reassured that the trial had been robustly carried out and were
interested in feedback from qualitative interview data about participant use of the Stop Smoking Services.
The stop smoking advisors were pleased and interested that the overall relapse prevention rates had been
better than the national average and were interested in how the trial rates compared with Norfolk
generally and with national figures. They suggested that the reduced relapse rates could possibly be a
result of the follow-up provided by the research team and advisors raising the subject of relapse with
participants as part of the recruitment process, and in particular asking them to sign forms. The normal
protocol in the service was to congratulate smokers on quitting and remind them not to have even one
puff in the future. It was thought that the focus on relapse prevention as the trial was recruiting may have
had an effect in itself in improving relapse rates in both trial groups. As a practical implication of this
possibility, the advisors suggested that the service could consider providing patients with a contract for
longer-term support to help encourage continued abstinence from smoking or to encourage relapsed
smokers to return to the service where relapse occurred.
Study 1c: findings from focus group discussions with
participants
Following completion of recruitment to the qualitative interview project, two focus groups were arranged
with trial participants. The aim of these participant focus groups was to feed back initial study findings as
well as to stimulate group discussion and further feedback on both the intervention and control materials.
We initially aimed to run four focus groups, across both trial and intervention group participants, and to
capture the views of those who had remained abstinent and those who relapsed back to smoking.
However, we found it difficult to gain agreement from those who had relapsed to attend focus groups.
Therefore, we ran two focus groups with those who had remained abstinent from smoking, further
capturing the views of 10 trial participants, across the control and intervention groups.
Demographically, those participating in the focus groups were broadly similar to those participating in the
trial for all parameters with the exception that younger participants (18–29 years) were not represented.
Both focus groups were audio-recorded, although transcription was not undertaken, as data were used for
verification of the qualitative analysis.
In general, findings from the focus groups supported the qualitative analysis reported (see Study 1a: qualitative
interviews with individual trial participants, Findings). Participants reported mixed responses to the intervention
booklets, with some reporting having read and engaged with the materials, and others reporting not reading
the booklets and not retaining them for future reference. Of note, two of the sample of 10 focus group
participants reported never having seen either the control leaflet or the intervention booklets. This is perhaps
significant given the small numbers of focus group attendees, although it may be a reflection of recall difficulty,
as some participants had entered the trial 2 or 3 years previously.
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Those attending the focus groups generally felt that the key to maintaining abstinence from smoking was
centred on internal motivation and a real drive to want to succeed. Prompts were given about the
usefulness of support and self-help materials, but the consensus was that no booklet or leaflet would be
sufficient to prevent relapse if the internal motivation to stay quit was not sufficiently strong. However,
once quit, and with a strong desire to stay quit, participants did report that it was useful to be able to refer
to information about the benefits of staying abstinent from smoking, and some suggested that looking
back at self-help materials assisted them with maintaining motivation to stay quit. However, there was a
general feeling that the form of self-help information could just as easily be a brief leaflet and that the
more extended support offered via the intervention booklets was superfluous.
As in the in-depth qualitative interview results, focus group participants reported that they did not gain any
significant new information, or at least at this time point could not recall any information, from the
self-help materials in comparison with the help and advice they had received from the Stop Smoking
Service. Participants spoke with fondness about their individual stop smoking advisors. They reported a
sense of increased motivation as a result of the regular initial meetings with stop smoking advisors, and
a sense of reward when they managed to maintain the quit and had this validated via a CO test with the
stop smoking advisor. In this sense, there was a general feeling that self-help support could be a useful
adjunct to the advice received during the one-to-one appointments with stop smoking advisors, but that
the one-to-one support, combined with the pharmacological support on prescription, was the key element
to their long-term successful quit attempt. The focus group participants echoed the interviews when they
reported enjoying the extended contact with the research team and the follow-up CO test at 12 months.
They suggested that this continued contact could be an addition to the Stop Smoking Service, and that
others might be encouraged to maintain a long-term quit attempt knowing that a follow-up appointment
would be arranged. Additionally, a number of focus group participants reported sharing the intervention
booklets with others (family members or friends), and that others had managed to stop smoking while also
referring to these booklets (see Study 1a: qualitative interviews with individual trial participants, Findings).
As focus groups were conducted following completion of the trial follow-up, for some participants the
initial quit date had been nearly 3 years previously. Interestingly, 8 out of the 10 participants attending
the focus group discussion reported that they had initially quit using varenicline as an aid. Focus group
participants were very keen to discuss varenicline and the consensus was that it worked remarkably well
for the initial cessation attempt.
Conclusions
The qualitative process analysis clearly shows a mixed response to self-help booklets for the prevention of
smoking relapse. Specifically with regard to the intervention booklets, participants seem to be either very
motivated and to have really engaged with the booklets, as demonstrated by the positive comments, or to
have disliked the booklets and in some cases not read them at all. For those reporting negative feelings
towards the booklets, the overall sense was that the booklets were not useful and did not offer any
particularly new or novel insights to what was already known about smoking relapse prevention. This may
be a result of the detailed advice that was received on a one-to-one basis via stop smoking advisors.
Indeed, participants were often able to recall advice delivered face to face but found it more difficult to
recall the content of the trial intervention booklets.
The self-help booklets were relevant and attractive to some, but not to all. This suggests that careful
targeting of self-help materials to those most receptive to the self-help approach may be a way forward
for smoking relapse prevention. Resources are wasted on those who do not enjoy reading or who find
engaging with self-help materials unhelpful.
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The self-help intervention booklets were experienced as particularly unhelpful by some participants, who
reported that they did not wish to be reminded of smoking. Again, this suggests that careful targeting
of intervention materials is appropriate, as some individuals may do better if they are able to distract
themselves during times of craving by focusing on something completely unrelated to smoking. For others,
it was helpful specifically to read the booklets, reinforce their own reasons for quitting and remind
themselves of the health benefits of staying stopped. It is potentially important for future service provision
that these differences in personality traits and approach be established by stop smoking advisors in order that
relevant advice and possible reference to self-help materials can be appropriately tailored.
The qualitative process evaluation data revealed that in some cases neither intervention nor control
materials were received by individuals. Similarly, a small minority of participants reported difficulty with
reading the study materials. Although recruitment attempted to screen for reading difficulties in order to
exclude participants who were unable to read or had difficulty with reading, clearly a number of
participants may have slipped through this screening net.
Many participants in the qualitative study, whether abstinent or relapsed, reported retaining and
sometimes referring back to the intervention booklets. Others reported their intentions of using the
booklets in future quit attempts. While there is likely to be some positive respondent bias impacting on
these reports, a potential benefit of self-help relapse prevention materials is that, if retained, they can be
reused and referred back to in future quit attempts. Conceptualising addiction to tobacco as a chronic
relapsing/remitting condition, and the task of achieving abstinence as a process or a cycle, suggests that
the longer-term impact of self-help materials may be important in supporting eventual abstinence.
Although this longer-term follow-up is beyond the scope of this study, recording data on use of self-help
materials over time is an area for future research in the field of monitoring of smoking behaviour.
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Chapter 7 Economic evaluation methods
and results
Overview
In order to estimate the cost-effectiveness of the intervention booklets compared with the control leaflet, a
within-trial cost–utility analysis was undertaken. In the base-case analysis, costs were estimated from the
perspective of the NHS and the EQ-5D was used to estimate QALYs. Participants were randomised at the
4-week quit point (baseline data were taken at this point) and followed up 2 months later (at the 3-month
follow-up point) and 11 months later (at the 12-month follow-up point).
Methods
Estimating costs
The study team monitored the levels of resource use associated with the intervention booklets (including
intellectual property, adaptation, printing and postage; this was also done for the control booklet.
Additionally, at the 3- and 12-month follow-up points, participants were asked to report how many of the
following items of resource use they had received:
l NHS Stop Smoking Clinic visits
l NHS Stop Smoking Clinic phone calls
l stop smoking aids (medication and materials)
l GP visits
l hospital admissions (and total number of days admitted, if applicable).
At the 3-month follow-up participants were asked about usage in the 2 months since randomisation, and
at the 12-month follow-up they were asked about usage the last 9 months. Together this enabled usage
to be estimated over the 11 months since the 4-week quit date (baseline data were taken at this point).
In relation to the medication (if applicable) participants were also asked whether or not they paid for this
themselves. In the base-case analysis,45 as the UK National Institute for Health and Care Excellence
methods guide46 recommends costs be calculated from the perspective of the NHS and Personal Social
Services, participant-borne medication costs were excluded. They were, however, included in a subsequent
sensitivity analysis.45
Costs were assigned to each of the aforementioned items of resource use, where these were estimated at
2012/13 financial year levels. Discounting was not undertaken, as the follow-up time was less than 1 year.
To estimate per-participant costs for the intervention and control booklets, the total cost was simply
divided by the number of participants in the arm in question.
Overall per-participant costs were estimated by summing the cost associated with each reported resource
item, plus the estimated cost of the intervention or control booklets (depending on the arm to which
the participant was allocated). Hereafter, this base-case analysis is referred to as the NHS perspective.
When participant medication costs are added, this is referred to as the NHS and participant medication costs.
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To estimate levels of health-related quality of life, participants were asked to complete the EQ-5D-3L36 at
baseline (the 4-week quit point), 2 months later (at the 3-month follow-up point) and 11 months later
(at the 12-month follow-up point). Responses were then converted into a utility score (a scale where death
is equal to 0 and full health 1) using the York A1 tarrif.47 The area under the curve method48 was then
used to estimate the QALY score over the 11-month period since baseline data were collected at the
4-week quit date (the EQ-5D score was assumed to change linearly), enabling a cost–utility analysis to
be undertaken.
Missing data assumptions
If a participant reported that he or she had a contact with the NHS Stop Smoking Clinics but did not
report the number of visits/phone calls, then the average value for those who reported these values was
used. Similarly, if a participant reported visiting visited his or her GP, or having been admitted to hospital,
but did not report the associated number of visits/days, the average value for those who reported these
values was used. If a respondent reported taking a particular medication, but did not report the associated
number of weeks, then the number of weeks was assumed to be equivalent to the average for those who
responded. If the participant did not report paying or otherwise for any of the medication he or she
reported having taken, it was assumed the NHS would have paid for it. All other missing data were left as
such and corresponding individuals were excluded from the analysis.
Analysis
The intention-to-treat strategy was used where patients were analysed within the group to which they
were allocated, regardless of, for example, whether or not they had used the booklet(s) in question. A
complete-case analysis approach49 was also adopted, whereby participants were included only if complete
cost and outcome data at all time points were available. In order to estimate the mean incremental cost
and incremental effect (QALY gain) associated with the intervention, compared with that for the control
group, regression analysis was undertaken. The system of seemingly unrelated regression equations50 was
used as it has been argued that such methods are generally robust to skewed data and to allow for any
correlation between costs and effects. The cost and QALY regressions were ran simultaneously, with
particular baseline demographic and smoking descriptive variables being included (as covariates) only if
all participants (for whom cost and effect data were available) had complete data for the covariate in
question and there was an a priori expectation that the covariate might be associated with cost and/or
QALY scores.
With regard to the interpretation of incremental cost and incremental effect data from the regression,
assuming that dominance45 did not occur, that is, that neither intervention nor control was on average
both more costly and less effective, the incremental cost-effectiveness ratio (mean incremental cost/mean
QALY gain)46 was calculated. However, if either the incremental cost and/or incremental effect were
negative, owing to the potential for misinterpretation, the incremental net benefit51 would be calculated at
the cost-effectiveness threshold (λ) value of £20,000 per QALY.46 Additionally, in order to estimate the
level of uncertainty associated with the decision as to whether or not the intervention was cost-effective,
we used the non-parametric bootstrap technique52 (with 5000 replications sampled with replacement) to
estimate the probability that each intervention was cost-effective according to the cost-effectiveness
acceptability curve (CEAC).53 The probability of the intervention being cost-effective was specifically
estimated at the λ of £20,000 per QALY.
An additional threshold analysis45 was also conducted to cater for the possibility that the control group
within this study may have received more than usual care – provision of a single leaflet containing key
messages for smoking relapse prevention. We therefore estimated what the incremental cost of the
intervention would have been on the basis of the intervention (Forever Free booklets) cost alone and then
assessed what QALY gain would be necessary, given such a cost, in order for the cost per QALY to fall
below the cost-effectiveness threshold (λ) value of £20,000 per QALY.46
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The number of people who completed the EQ-5D-3L questionnaire at baseline (the 4-week quite point),
the 3-month follow-up and 12-month follow-up was 682 (97.0%), 644 (91.6%) and 574 (81.7%)
respectively in the intervention group and 666 (94.7%), 646 (91.9%) and 597 (84.9%), respectively, in the
control group. Based on these data, QALY scores could be calculated for 537 (76.4%) intervention
participants and 530 (75.4%) control participants. In relation to costs, the response rate varied across
resource items – the number who completed both the resource item questions at 3 and 12 months varied
between 555 (78.9%) for the intervention group and 574 (81.7%) for the control group in relation to
hospital admissions, and 570 (81.1%) and 585 (83.2%) respectively for stop smoking medication. Overall
costs were available for 549 (78.1%) and 570 (81.1%) participants respectively. Finally, a total of 521
(74.1%) intervention participants and 528 (75.1%) control participants completed all three EQ-5D
questionnaires and each of the 3 and 12-month follow-up cost questionnaires, this group constitutes the
complete-case group on which all subsequent analyses are based.
Costs
The estimated costs associated with the provision of the intervention and control booklets are outlined in
Tables 20 and 21. Levels of other items of resource use, as reported by participants, are given in Tables 22 and
23. It can be seen that the levels of resource use are broadly similar across groups. The unit costs which were
assigned to these resource items, along with details of the associated sources and assumptions, are outlined in
Table 24. This enabled the overall (unadjusted) costs (from the perspective of the NHS), along with the total
cost for each component item of resource use, to be calculated (see Table 22). The mean overall (unadjusted)
NHS costs were estimated to be higher in the control group. However, it should be noted that this difference
can largely be accounted for by hospital admission costs and the fact that one participant in the control group
reported spending 98 days in hospital.
TABLE 20 Intervention costs
Component part Total cost (£) Per-participant cost (£)
Copyright (booklets previously used in the USA)a 1562.50 2.22
Revisions to the booklets 2500.00 3.56
Printing costs 8661.60 12.32
Postage (£2.68 per pack, sent to 703 participants) 1884.04 2.68
Total 14,608.14 20.78
a Cost was US$2500 (exchange rate of GBP1.00=US$1.60 was assumed).
TABLE 21 Control costs
Component part Total cost (£) Per-participant cost (£)
Purchase of booklets, including printing 217.50 0.31
Postage (0.36p, sent to 704 participants) 253.44 0.36
Total 470.94 0.67
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TABLE 22 Per participant mean levels of resource use and associated costs
Item
Levels of resource use Mean cost (£)
Intervention Control Intervention Control
NHS Stop Smoking Clinic visits 2.25 2.29 31.45 32.12
NHS stop smoking phone call 0.27 0.31 0.95 1.09
Stop smoking medication (NHS perspective) 110.35 117.07
Stop smoking medication (NHS and individual perspective) 134.71 143.99
NHS Quit kit 0.04 0.05 0.04 0.05
GP visits 4.55 4.56 168.53 168.86
Hospital admissions (days) 0.63 0.97 221.67 338.08
Provision of intervention booklets 20.78 –
Provision of control booklets – – – 0.67
Overall costs (NHS perspective) – – 553.78 657.95
Overall costs (NHS and participant medication costs) – – 578.14 684.87
TABLE 23 Per participant mean levels of resource use for stop smoking medication and associated costs
Item





(£, NHS and individual
medication perspective)
Intervention Control Intervention Control Intervention Control
Bupropion 0.03 0.04 0.63 0.80 0.63 0.80
Varenicline 2.94 3.08 49.74 52.12 49.74 52.12
Nicotine gum 0.63 0.53 1.92 2.08 4.03 3.44
Nicotine patches 2.13 2.39 19.78 23.41 24.84 27.15
Nicotine microtabs 0.57 0.72 2.98 2.27 4.54 5.76
Nicotine lozenges 1.34 1.23 4.38 4.19 10.04 9.24
Nicotine inhalator 1.70 2.11 18.17 21.18 24.93 30.95
Nicotine nasal spray 0.05 0.11 0.81 0.85 0.81 1.77
Nicotine mouth spray 1.30 1.09 11.95 10.16 15.14 12.75
The number of weeks for which each type of resource was reported to have been taken is shown, regardless of whether or
not the item was paid for by the individual.
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Outcomes
European Quality of Life-5 Dimensions-3-Level scores at baseline, 3-month follow up and 12-month follow-up
are given in Table 25. Again, it can be seen that these scores are broadly similar in the two groups; this also
applies to the QALY scores, which were calculated from the EQ-5D-3L scores.
Analysis
The results of the seemingly unrelated regression are shown in Table 26, where it can be seen that there
was no significant difference between either the overall cost (NHS perspective) or the QALY score between
the two groups. As the incremental cost and QALY gain were both (slightly) negative, we estimated the
mean incremental net benefit [at the (λ) value of £20,000 per QALY] to be £74.79. This positive value
would indicate that the intervention was estimated to be cost-effective. However, the CEAC shows that
there is a large uncertainty associated with this result, as the intervention has only a 64.4% probability of
being cost-effective at this level, that is there would be a 35.6% chance of making the wrong decision by
choosing to implement the intervention.
TABLE 24 Unit costs assigned to different resource items, with associated source/assumptions
Item Estimated unit cost (£)
NHS Stop Smoking Clinic visita 14.00
NHS stop smoking phone callb 3.50
Bupropion (weekly cost)c 19.24
Varenicline (weekly cost)c 16.93
Nicotine gum (weekly cost)c 6.44
Nicotine patches (weekly cost)c 11.64
Nicotine microtabs (weekly cost)c 8.00
Nicotine lozenges (weekly cost)c 7.52
Nicotine inhaler (weekly cost)c 14.69
Nicotine nasal spray (weekly cost)c 16.21
Nicotine mouth spray (weekly cost)c 11.66
NHS Quit kit (weekly cost)d 1.00
GP visite 37.00
Hospital admission – cost per dayf 349.12
a Provided by level 3 stop smoking advisors, all visits were assumed to last 20 minutes (contact time). Curtis54 estimated
that a 10-minute smoking advice session would cost £7 with a practice nurse. These staff members are on an equivalent
grade to the stop smoking advisors; consequently, we doubled this cost in order to estimate the visit cost in question.
b Provided by level 3 stop smoking advisors and assumed to last 5 minutes. Based on this, a half of the cost of a
10-minute advice session with a practice nurse was included.
c Costs (where unit costs were weighted by prescription volume) were taken from the Prescription Cost Analysis for
England,55 it was assumed that prescriptions would last for 2 weeks.
d https://quitnow.smokefree.nhs.uk/. We were unable to identify an associated cost. This assumed cost was informed by
the aforementioned resources/cost associated with the control booklet.
e Data from Personal and Social Services Research Unit.54
f Data from NHS Reference Costs,56 which is the mean elective in-patient excess bed-day cost.
TABLE 25 Mean EQ-5D-3L scores (SD) by group
Intervention group Baseline 3-month follow-up 12-month follow-up QALY
Intervention 0.832 (0.256) 0.825 (0.251) 0.814 (0.254) 0.753 (0.204)
Control 0.821 (0.254) 0.821 (0.242) 0.806 (0.255) 0.747 (0.196)
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The results of the sensitivity analysis (NHS and participant medication costs) were virtually identical to that
of the base case (see Table 26), although the slightly lower mean incremental cost resulted in a slightly
higher incremental net benefit (£78.20) and probability of cost-effectiveness (66.1%).
The cost of providing the Forever Free booklets was estimated to be £20.78. Threshold analysis indicated
that, in order for the cost per QALY to fall below the threshold of £20,000 per QALY, a QALY gain
> 0.0010 would be required. Taking account of the fact that the area under the curve technique is used
estimate the QALY, a utility gain of 0.0013 would thereby be required for the cost per QALY to fall below
that threshold.
Summary
A complete-case within-trial analysis was conducted, with costs estimated from an NHS viewpoint. Based
on regression analysis, it was estimated that there was no significant difference in mean costs or mean
QALY scores between the intervention and control groups. Although the estimated mean incremental net
benefit was positive (£74.79), the probability of cost-effectiveness was estimated to be only 64.4%
according to the CEAC (based on λ= £20,000 per QALY). Coupled with the aforementioned effectiveness
results, this would suggest that we are not able to conclude that the provision of the intervention booklets
is cost-effective.




Costs (NHS perspective, £),
(95% CI)
Costs (NHS and participant




–84.49 (–280.96 to 111.98) –87.89 (–284.33 to 108.54) 0.000 (–0.017 to 0.016)
EQ-5D baseline score –1269.74 (–1686.84 to –852.64) –1254.09 (–1671.13 to –837.05) 0.536 (0.501 to 0.517)
Gender (female
vs. male)
–38.84 (–246.21 to 168.53) –55.33 (–262.67 to 152.01) 0.014 (–0.003 to 0.031)








–119.07 (–532.29 to 294.15) –136.70 (–549.86 to 276.46) –0.001 (–0.035 to 0.034)
Retired vs. in
paid employment
253.92 (–80.63 to 588.48) 250.67 (–83.84 to 585.18) –0.031 (–0.059 to –0.003)
Other vs. in
paid employment
465.08 (122.81 to 807.35) 472.28 (130.06 to 814.50) –0.026 (–0.054 to 0.003)
Number of cigarettes per day before quitting
11–20 vs. ≤ 10 191.73 (–95.46 to 478.92) 188.33 (–98.82 to 475.48) –0.004 (–0.028 to 0.020)
> 20 vs. ≤ 10 307.69 (–17.79 to 633.19) 311.61 (–13.82 to 637.05) –0.020 (–0.047 to 0.008)
Constant 1496.82 (827.66 to 2165.98) 1509.78 (840.71 to 2178.85) 0.353 (0.297 to 0.409)
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Chapter 8 Discussion
This randomised controlled trial compared the effect of a set of eight revised Forever Free booklets anda control leaflet on the prevention of smoking relapse in 4-week quitters who used NHS Stop Smoking
Services. The trial randomised 1407 eligible 4-week quitters, and the follow-up rate was 93% at the
3-month follow-up and 86% at the 12-month follow-up. The trial results indicate that there were no
significant differences between the treatment and the control group in terms of the primary end point
(36.9% vs. 38.6%) and any secondary smoking outcomes at 12 months after quit date (see Table 6).
There was no evidence that people in the intervention group developed more skills and responses believed
to be necessary to prevent relapse than those in the control group. Our qualitative study also found mixed
results, with participants either liking or strongly disliking the intervention booklets.
Comparison with other relevant evidence
According to findings from two systematic reviews, self-help educational booklets were effective in
preventing smoking relapse in unaided quitters.23,24 For example, the pooled OR of self-help booklets for
smoking relapse prevention in unaided quitters was 1.52 (95% CI 1.15 to 2.01),24 based on data from
three randomised trials.25,26,57 Specifically, two of the three trials included in the meta-analysis25,26 found
that a set of eight Forever Free booklets was more effective than a single introduction booklet for the
prevention of smoking relapse in unaided quitters. However, results from the current trial indicate that the
full set of Forever Free booklets was no more effective than a single leaflet in short-term quitters who
received behavioural support to stop smoking (Figure 18). To be comparable with the outcome reported
in other trials, the outcome used in Figure 18 was self-reported smoking prevalence at the end of the
follow-up. The difference in the OR for self-reported smoking prevalence between the current trial and
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FIGURE 18 Results of the current and previous trials: self-reported point smoking prevalence.
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It is worth considering possible explanations for the different findings in the present study compared with
the two previous studies using a very similar intervention.25,26 Whereas the present study found no
outcome differences between the intervention and control conditions, the previous studies both reported
statistically significant group differences among recent unaided quitters. The following key differences
between the studies might provide insight into the discrepant findings.
l The original studies were conducted in the USA more than 10 years ago, whereas the present study
was conducted in the UK. Aside from the other differences noted below, it is possible that cultural
differences interfered with the efficacy of the booklet, even though surface structure adaptations
were enacted.
l The booklets were originally developed to aid self-quitters in place of more intensive face-to-face
treatment, and the previous studies involved those smokers. In contrast, the present study used the
booklets as an extension of an intensive face-to-face intervention provided by the NHS Stop Smoking
Clinics. Indeed, the abstinence rates achieved in this study exceeded even the typical rates reported for
NHS clinics. Thus, smokers in the present study may have received unusually high-quality treatment,
which may have rendered the booklets superfluous. That said, it is worth noting that many participants
still had no strategy to deal with urges to smoke. Previous research found little effects of the booklets
among (1) individuals who had been abstinent for more that 3 months at the time of enrolment,25
(2) telephone quitline callers who had received NRT58 and (3) pregnant women from higher income
groups.59 This pattern suggests that the booklets have greatest effect among those receiving
suboptimal assistance with their efforts to quit smoking.
l The present study achieved outstanding follow-up rates by using a series of strategies to keep
participants engaged in the study. Moreover, follow-up assessments were inclusive and conducted
by phone or in person. In contrast, the previous studies collected follow-up data via brief mailed
questionnaires with the goal of minimising possible reactance effects. It is possible that follow-up
procedures used in the present study enhanced the treatment effect, thereby further limiting the
additional effect of the intervention.
l The eight booklets were originally developed to be distributed to smokers over the course of year, with
the goal of maintaining their motivation to quit throughout this period. However, one study found that
the booklets were equally efficacious when delivered all at once.26 For this reason, we sent participants
all eight booklets at once in the present study. However, in retrospect, this bulk mailing immediately
after the NHS intervention may have increased the tendency for respondents to feel the intervention
was somewhat redundant. Perhaps it may have been better to have delivered this intervention as a
series of mailings over the follow-up period, when they might have served to both maintain abstinence
motivation and remind participants of key messages from counselling.
The self-reported abstinence at 12 months was on average 52% and the continuous CO-validated
smoking abstinence from months 2 to 12 was on average 32% (95% CI 30% to 35%) in the current
study (see Table 6). These secondary smoking end points may be more comparable to the smoking
outcome used in other longer-term studies of 4-week quitters in NHS Stop Smoking Services.13,60,61 The
prevalence of both continuous CO-validated abstinence and self-reported abstinence by 12 months was
significantly higher in the current study than the estimates from other studies (Table 27).
It is interesting to explore possible reasons for differences in smoking abstinence across these studies of
4-week quitters in NHS Stop Smoking Services. All studies in Table 27 recruited CO-validated 4-week
quitters in NHS Stop Smoking Services. The average age and sex of the participants were similar across
studies, although there may be some differences in other participant characteristics. Compared with the
rest of England, Norfolk has a relatively high proportion of people aged ≥ 65 years (21.4% vs. 16.5% in
2010) and a higher percentage of European white people (94.3% vs. 87.5% in 2009). The current trial
excluded pregnant women, quitters who were not able to read educational materials in English and those
in prisons. It is likely that the two observational studies may be more inclusive, by including all CO-validated
4-week quitters who gave consent to participate in the study. Although some participant characteristics at
baseline are associated with the risk of smoking relapse, it is not always possible to compare all participant
characteristics across the studies because of differences in ways of measuring and reporting.
DISCUSSION
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The study by Ferguson et al.13 and the study by Bauld60 were observational studies, and the study by Snuggs
et al.61 was a single-arm pilot trial of text messaging for relapse prevention. No additional supports were
provided to study participants in the two observational studies. In the pilot study by Snuggs et al.,61 mobile
phone text messages for relapse prevention were sent to study participants weekly for 12 weeks and then
fortnightly for up to 6 months. Owing to the single-arm design and the large percentage of participants lost
to follow-up (32%), it was unclear whether or not smoking abstinence was improved by the intensive text
messaging intervention. In comparison, the SHARPISH trial was a randomised controlled study of a self-help
intervention for smoking relapse prevention. All participants in the current study received a telephone follow-up
interview at 3 months after quit date. Participants in the treatment group received a set of eight Forever Free
booklets, and participants in the control group of the current trial also received a leaflet for smoking relapse
prevention. We may therefore presume that the telephone follow-up intervention at 3 months and the brief
educational leaflet might have reduced smoking relapse at 12 months. Indeed, anecdotal evidence from our
qualitative study suggested that participants enjoyed participating in the study and were aware that they would
be contacted by a researcher, which may have had a motivating effect on smoking abstinence. However,
previous evidence summarised in a Cochrane systematic review19 indicated that extended interventions were
not effective for preventing smoking relapse. A more recently published pilot study also reported that smoking
abstinence at 52 weeks was not increased by extended interactive voice response telephony in aided quitters.62
Participants lost to follow-up were counted as being relapsed in the three studies. The percentage of
participants who were lost to follow-up was 15% in the current study, compared with 22% in Bauld et al.,60
27% in Ferguson et al.13 and 32% in Snuggs et al.61 If some participants who were lost to follow-up
remained abstinent, the low rate of loss to follow-up in the current study (15%) may have contributed to a
high-rate of smoking abstinence at the follow-up.
In comparison with other published trials, our study is the only one to have included a detailed qualitative
process evaluation. This enables us to interpret the trial findings considering the participant perspective of
reported use of the intervention and control materials.
In terms of cost-effectiveness, we are aware of only one other paper that has assessed the cost-effectiveness of
a similar intervention.26 Brandon et al.26 estimated only the cost of the intervention (a one-off mailing of the
booklets compared with repeated mailing/letters) and included QALY estimates based on assumptions about
how changes in quit rates would translate into QALYs. Their estimates of the intervention costs (US$21.15 to
US$43.94, year 2000 price estimates) were comparable to ours, but there were differences in the mean
incremental QALY gain. Brandon et al.26 estimated the mean incremental QALY gain to be between 0.2561
and 0.2741, where these differences are likely to largely arise because, in contrast to our study, the booklets
were found to be effective at increasing quit rates.
Generalisability
The results of the trial may not be generalisable to pregnant women, people younger than 18 years and
those who are not able to read English as these groups were excluded. In addition, 98% of the study
participants are European white, and the trial results may not be generalisable to ethnic minority quitters.
Of the 1959 eligible 4-week quitters, 19% (n= 370) declined study participation for various reasons
(see Figure 2). Short-term quitters who consented to participate in the study may be systematically
different from other eligible quitters who declined. Using data routinely collected by the Norfolk Stop
Smoking Service, we examined the comparability of study participants and other short-term quitters in
Norfolk. Data extraction from the Stop Smoking Service database was undertaken by the information
technology department at the Norfolk Community Health and Care Trust. We obtained data on all
episodes in which a CO-verified quit was recorded, for the period 1 August 2011 (commencement of
SHARPISH recruitment) to 31 May 2013 (close of SHARPISH to recruitment), a total of 22 months. These
data must be viewed with a certain amount of caution as improving data recording and data quality was
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an ongoing process during the period of the trial and it is acknowledged that the records held on the
database for this period are not absolutely complete.
There were a total of 5186 CO-verified quits recorded in the period. The number of recorded events was
4626, after excluding prisoners, persons in secure hospitals and the Royal Air Force, young people under
18 years and duplicates episodes for the same individuals. The basic characteristics of study participants
and other CO-validated short-term quitters in Norfolk are shown in Table 28. The average age of study
participants and non-participants was similar (median 47 years), but there were slightly (although
statistically significantly) fewer male quitters in the SHARPISH study (47% vs. 51%). The study participants
had a higher percentage of managerial/professional occupation (18% vs. 15%), a higher percentage of
intermediate occupation (9% vs. 5%) and a lower percentage of routine/manual occupation (29% vs. 33%).
TABLE 28 Basic characteristics of study participants and other short-term quitters in Norfolk
Characteristics
Norfolk SHARPISH Norfolk ALL minus Norfolk SHARPISH
p-valuen % n %
Total 1199 100 3427 100 –
Age, years (median) 47 – 47 – –
Sex: male 563 47 1749 51 0.015
Occupationa
Full-time student 15 1 24 1 0.073
Home carer 87 7 195 6 0.051
Intermediate 112 9 178 5 < 0.001
Managerial/professional 213 18 504 15 0.012
Never worked/long-term unemployed 75 6 249 7 0.238
Retired 236 20 600 18 0.091
Routine/manual 347 29 1123 33 0.0143
Sick/disabled unable to work 95 8 239 7 0.274
Unable to code 19 2 315 9 < 0.001
Treatment episode numberb
One 705 59 2412 70 < 0.01
Two 278 23 733 21 < 0.01
Three or more 178 15 321 9 < 0.01
Unknown 38 – 0 – –
Smoking cessation medication received in first 4 weeks after quit datec
NRT 476 40 1880 54 < 0.001
Varenicline 694 48 1484 43 < 0.001
Bupropion 5 0.4 21 0.6 0.435
None 3 0.3 21 0.6 0.133
Unknown 22 2 68 2 0.747
a Database definitions.
b Total number of quitters (Norfolk all –Norfolk SHARPISH) was n= 3466.
c Some patients may be given more than one treatment.
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The study participants were less likely to be in their first episode of treatment with the Norfolk Stop
Smoking Service than other CO-verified quitters (61% vs. 70%). Compared with non-participants in
Norfolk, relatively more study participants received varenicline (48% vs. 43%) and relatively fewer study
participants used NRT (40% vs. 54%) in terms of smoking cessation treatment medication (see Table 28).
Therefore, it is possible that study participants may be associated with relatively more favourable longer-term
abstinence outcomes than non-participants. The differences were generally small or moderate, even though
such differences tended to be statistically significant because of the large sample size. The results of exploratory
analyses (see Table 7) indicated that the effect of the experimental booklets was not significantly modified by
participant characteristics at baseline. Therefore, the relative effect of the experimental and control booklets on
smoking abstinence at 12 months estimated by the current study should be generalisable to other short-term
quitters who used NHS Stop Smoking Services in Norfolk.
Strengths and limitations
The current trial successfully achieved the recruitment target, and randomised 1407 eligible CO-validated
short-term quitters, which is the largest such study so far. The percentage of participants who were lost to
the final follow-up at 12 months was low (15%) compared with other studies that evaluated longer-term
smoking relapse outcomes in 4-week quitters who used NHS Stop Smoking Services (see Table 27).
The prespecified primary outcome is prolonged (with fewer than five cigarettes from months 4 to 12)
CO-validated abstinence at 12 months. Participant allocation was adequately concealed and the main
characteristics of participants were well balanced at baseline. The estimated 95% CI was narrow for the
primary outcome (OR 0.930, 95% CI 0.749 to 1.154), which did not include the assumed average OR
(1.44). Therefore, the statistical power was adequate to detect the assumed difference in smoking
outcomes if it was true. Therefore, we are confident that there is no clinically important difference in
smoking outcomes at 12 months between the intervention groups.
As with practically all behavioural interventions it was not possible to blind participants and investigators to
allocation for follow-up. The primary and other smoking results are unlikely to be biased because of lack
of blinding,29 although bias might have been introduced in the measurement of process and mediating
variables such as reported reading of educational materials and feedback on the perceived helpfulness
of the educational booklets. However, these assessments also showed few differences between the
intervention and the control groups and therefore are unlikely to have played a role here.
Although there were no significant differences in smoking relapse between the experimental and the
control groups, the overall rate of smoking abstinence at 12 months was relatively high in the current trial
compared with other studies of short-term quitters in the NHS Stop Smoking Services (see Table 27). In
addition to the follow-up interview at 3 months, the participants in the control group also received a single
leaflet containing key messages for smoking relapse prevention and a telephone contact at 3 months.
Additional to other possible explanations, a brief leaflet may be effective to reduce smoking relapse in
short-term quitters. However, we could not be certain because the current trial had not included a control
group without follow-up interview at 3 months and educational leaflet.
This study included a qualitative process evaluation. This is a strength of the approach as the qualitative
study allows for further interpretation of the trial findings from a participant perspective. We found mixed
responses to the intervention booklets, suggesting that some participants may be more receptive to
self-help information than others, although we were not able to assess openness and willingness to accept
to the self-help approach (psychological characteristics) as part of the trial.
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Interpretation and implications
The main participant characteristics were comparable at baseline between the intervention and the control
groups. The proportion of prolonged (from 4 to 12 months) CO-validated abstinence at 12 months after
quit date was 36.9% in the intervention group and 38.6% in the control group. There was no statistically
significant difference between the groups (OR 0.93, 95% CI 0.75 to 1.15). In addition, there were no
statistically significant differences between the groups in other secondary smoking outcomes, such as
7-day self-reported point smoking prevalence, and verified smoking abstinence at the final follow-up.
Subgroup and regression analyses did not reveal moderating effects of any baseline characteristics on the
efficacy of the intervention. The current trial had adequate statistical power so that the result is unlikely to
be false negative. Therefore, the convincing evidence from this randomised trial does not support the
use of more self-help educational materials than a single leaflet for smoking relapse prevention in
short-term quitters in smokers who have received behavioural support.
To interpret the trial results, it is important to remember the hypothesised mechanisms of coping skills
training for relapse prevention. Self-help educational materials could be effective if:
l quitters have received and read the self-help educational materials
l by reading the self-help educational materials, quitters have learnt new skills or reinforced their skills to
identify risky situations and to do something to handle smoking urges
l quitters have actually done something to avoid high risky situations and/or something to cope with
smoking urges.
In addition to these points, we hypothesised that the eight Forever Free booklets were more effective than
a single leaflet containing the similar but much briefer points for smoking relapse prevention (see Table 1).
In the current trial, we collected data on process variables relevant to the hypothesised mechanisms.
Compared with participants in the control group, relatively more participants in the Forever Free booklet
group who reported that they had received the booklets (89% vs. 79%) at the 3-month follow-up, and
reported that still had the booklets at 3 months (83% vs. 62%) and at 12 months (49% vs. 35%). The
differences in the reported receipt and keeping of the self-help educational material between the two
groups may be because a set of eight booklets used in the treatment group was more noticeable or
substantial than a single leaflet used in the control group. In addition, reporting bias could not be rule out.
The proportions of participants who reported that they had read the booklets (or the leaflet) were similar
(70% vs. 69%) at the 3-month follow-up. However, only small percentages of participants in both the
treatment and control group reported that they had read the self-help material from 4 to 12 months
(27% vs. 21%). In addition, participants in the treatment group reported that they spent somewhat more
time reading the educational material than those in the control group. The embedded qualitative study
revealed occasional instances when participants reported looking up the booklets to see how to deal with
difficult situations, but this was uncommon. Participants regarded much of the material as nicely presented
but nothing new, and the overall impression was that it lacked impact.
There were no significant differences between the groups in the percentages of participants who reported
they knew any (little or much) more about relapse risky situations (52% vs. 51%) or ways of handling
urges (51% vs. 51%) by the 12-month follow-up. More importantly, there were no differences between
the groups in the percentages of participants who reported that they had attempted to do something to
cope with urges between 2 and 3 months (83% vs. 83%) and between 4 and 12 months (60% vs. 61%).
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All study participants had received intensive behavioural support from stop smoking advisors before
participating in the trial, and most of them (89%) had previously attempted to quit. In addition, after
quitting smoking at 4 weeks, 60% of the participants contacted NHS stop smoking advisors during
months 2–3, and 15% did so from months 4 to 12. Therefore, it is very likely that they had received
information from stop smoking advisors similar to that in the Forever Free booklets. The qualitative
interviews found that study participants could recall some advice received from stop smoking advisors,
while they found it difficult to recall the information contained in the booklets. Nevertheless, the booklets
and the advisors between them failed to give many people the skills they needed to avoid relapsing or
many participants failed to apply a coping strategy where required.
Previous studies reported that smoking cessation support by specialist stop smoking advisors was associated
with a higher short-term quit rate (4 weeks after the quit date) compared with support by non-specialists
(for example, GPs or pharmacists).63,64 Data from the current study revealed that the percentage of participants
who reported prolonged smoking abstinence was higher among those receiving specialist core services than
among those receiving non-specialist services (39% vs. 32%; p= 0.023). Further research is required to
investigate this difference between specialist and non-specialist stop smoking advisors.
In agreement with evidence from previous studies,65,66 reported attempts by study participants to do
something to cope with urges were associated with a lower risk of smoking relapse. Forty per cent of
participants who reported they did something to cope with urges between 2 and 3 months remained smoking
abstinent from months 4 to 12, compared with 28% of participants who did not. The difference in smoking
abstinence was more considerable between any strategies and no strategies from months 4 to 12 (48% vs.
23%) (see Figure 16). The results of further exploratory analyses (see Table 15) revealed that the percentage of
smoking abstinence from months 4 to 12 was lowest, at both the 3- and the 12-month follow-ups, among
participants who reported no strategies at all (19%) and the highest among participants who attempted
strategies (48%). The percentage of participants who reported smoking abstinence from months 4 to 12 was
slightly higher among those who reported strategies only at the 3-month follow-up than among those who
reported no strategies at all (24% vs. 19%). These results indicate that continued efforts are needed to enable
quitters to help cope with smoking urges and prevent smoking relapse. The full set of eight Forever Free
booklets was no more effective than a single leaflet in increasing the strategies by study participants to do
something to cope with smoking urges, as there was no difference between the two trial groups in the
percentage of participants who attempted to do something.
In summary, there were some small differences in the percentage of participants who recalled having had
the booklets and reading them. However, there were no differences in the percentage of participants who
reported that they knew any more about coping skills between the groups and no differences in reported
actual strategies to handle smoking urges between the trial groups. Therefore, the risk of longer-term
smoking relapse was not affected by posting the full set of revised Forever Free booklets to people who
had achieved 4 weeks of abstinence with the aid of behavioural support and medication compared with a
single leaflet containing a similar but briefer message for smoking relapse prevention.
Indirect evidence comparing the results of different non-randomised studies indicated that a telephone
follow-up, along with a single leaflet, may reduce smoking relapse at 12 months in 4-week quitters who
have used NHS Stop Smoking Services. However, in a pilot study,61 mobile phone text messages were
sent to 4-week quitters weekly for 12 weeks and then fortnightly up to 6 months. Given the intensive
frequency of text messaging, the smoking abstinence rate at 6 months in that study61 was still much lower
than the rate of smoking abstinence at 12 months in the current trial (see Table 27). In addition, evidence
from other previous studies does not support the use of extended non-pharmacological interventions for
preventing smoking relapse.19,62 Reasons for the lower risk of smoking relapse in the current trial were
uncertain because of the between-study differences in design, participant characteristics at baseline and
different rates of participants lost to follow-up.
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Qualitative data indicated that some 4-week quitters found continued interventions for smoking relapse
prevention unhelpful and even harmful, although positive feedback from study participants was also
common. According to the results of exploratory quantitative analyses, there was no clear dose–response
relationship between smoking relapse and the use of self-help educational material-related process
variables. Therefore, it is unlikely that smoking relapse could be reduced simply by sending more self-help
educational materials to short-term quitters in the NHS Stop Smoking Services.
Despite these caveats, it is important to note that most participants relapsed and many failed to have
simple strategies to deal with urges to smoke and could not identify risky situations. For reasons that we
can only speculate on, the booklets proved to be an unengaging intervention that participants did not
attend to sufficiently to gain or improve these coping skills.
Conclusions
Implications for smoking cessation
Initially developed for, and validated on, unaided self-quitters, the full set of the revised Forever Free
booklets was not found to provide additional benefit to short-term quitters who already receive intensive
behavioural interventions. Compared with a single leaflet, the actual use of coping skills for smoking
relapse prevention was not further improved in 4-week quitters by receiving the full set of eight revised
Forever Free booklets. The risk of smoking relapse could not be reduced simply by posting more
information to CO-validated 4-week quitters in NHS Stop Smoking Services. Our qualitative study
confirmed that many participants felt that the content of the booklets did not significantly enhance the
detailed advice and support that they had already received via the NHS Stop Smoking Service.
Recommendations for further research
l Actual use of coping skills is associated with a lower risk of long-term smoking relapse. Further
research should focus on interventions that may increase the use of coping skills when required.
In particular, participants in this study reported that they had heard all the material in the booklets
previously; however, when asked to identify risky situations, many could not do so and many had no
strategy to combat urges to smoke. Behavioural support tends to involve smokers in the passive role of
soaking up information. Finding ways to elicit and practise strategies during face-to-face support may
prove more effective in preventing relapse.
l Our qualitative study suggested that targeting of self-help interventions may be appropriate, as some
seemed more receptive to this approach than others. This warrants further investigation.
l Reasons for different longer-term smoking outcomes across different studies and among individual
4-week quitters need to be investigated. Improved understanding of variables related with smoking
relapse may help develop novel interventions for smoking relapse prevention.
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